423:
730:). When the Wnt pathway is not active, GSK3B is able to phosphorylate TSC2 on Ser1341 and Ser1337 in conjunction with AMPK phosphorylation of Ser1345. It has been found that the AMPK is required to first phosphorylate Ser1345 before GSK3B can phosphorylate its target serine residues. This phosphorylation of TSC2 would activate this complex, if GSK3B were active. Since the Wnt pathway inhibits GSK3 signaling, the active Wnt pathway is also involved in the mTORC1 pathway. Thus, mTORC1 can activate
558:
829:
8993:
33:
1190:. Its upregulation has been shown to cause premature aging in hematopoietic stem cells. Conversely, inhibiting mTOR restores and regenerates the hematopoietic stem cell line. The mechanisms of mTORC1's inhibition on proliferation and differentiation of hematopoietic stem cells has yet to be fully elucidated.
413:
The role of mTORC1 is to activate translation of proteins. In order for cells to grow and proliferate by manufacturing more proteins, the cells must ensure that they have the resources available for protein production. Thus, for protein production, and therefore mTORC1 activation, cells must have
487:
on the surface of the lysosome in response to amino acid levels in the cell. Even if a cell has the proper energy for protein synthesis, if it does not have the amino acid building blocks for proteins, no protein synthesis will occur. Studies have shown that depriving amino acid levels inhibits
1130:. When this electron transport chain is not as efficient, the unreduced oxygen molecules in the mitochondrial cortex may accumulate and begin to produce reactive oxygen species. It is important to note that both cancer cells as well as those cells with greater levels of mTORC1 both rely more on
468:
of the complex. This phosphorylation can cause the dimer to dissociate and lose its GAP activity, or the phosphorylation can cause the heterodimer to have increased GAP activity, depending on which amino acid residue becomes phosphorylated. Thus, the signals that influence mTORC1 activity do so
1051:
mTORC1's ability to inhibit autophagy while at the same time stimulate protein synthesis and cell growth can result in accumulations of damaged proteins and organelles, contributing to damage at the cellular level. Because autophagy appears to decline with age, activation of autophagy may help
1467:
is resistant to rapamycin, and it too acts upstream of mTORC1 by activating Akt. Thus signaling upstream of mTORC1 still remains very active upon its inhibition via rapamycin and the rapalogs. Rapamycin and its analogues also have procoagulant side effects caused by off-target binding of the
848:(eIF4E) binding protein 1, primarily via phosphorylation and dephosphorylation of its downstream targets. S6K1 and 4E-BP1 modulate translation in eukaryotic cells. Their signaling will converge at the translation initiation complex on the 5' end of mRNA, and thus activate translation.
1511:
The third generation of inhibitors were created following the realization that many of the side effects of rapamycin and rapamycin analogs were mediated not as a result of direct inhibition of mTORC1, but as a consequence of off-target inhibition of mTORC2. Rapamycin analogs such as
500:
where the Rheb-GTP is located. This allows mTORC1 to physically interact with Rheb. Thus the amino acid pathway as well as the growth factor/energy pathway converge on endosomes and lysosomes. Thus the
Ragulator-Rag complex recruits mTORC1 to lysosomes to interact with Rheb.
785:
AMPK can also phosphorylate Raptor on two serine residues. This phosphorylated Raptor recruits 14-3-3 to bind to it and prevents Raptor from being part of the mTORC1 complex. Since mTORC1 cannot recruit its substrates without Raptor, no protein synthesis via mTORC1 occurs.
459:
of the active Rheb-GTP complex, converting it to the inactive Rheb-GDP complex. The active Rheb-GTP activates mTORC1 through unelucidated pathways. Thus, many of the pathways that influence mTORC1 activation do so through the activation or inactivation of the TSC1/TSC2
986:, fruitflies, and mice. Inhibition of mTORC1 showed significantly increased lifespans in all model species. Disrupting the gut microbiota of infant mice was found to lead to reduced longevity with signaling of mTORC1 implicated as a potential mechanism.
591:
to TSC2, disrupting the TSC1/TSC2 dimer. When TSC2 is not associated with TSC1, TSC2 loses its GAP activity and can no longer hydrolyze Rheb-GTP. This results in continued activation of mTORC1, allowing for protein synthesis via insulin signaling.
1453:
The second generation of inhibitors were created to overcome problems with upstream signaling upon the introduction of first generation inhibitors to the treated cells. One problem with the first generation inhibitors of mTORC1 is that there is a
681:. Erk will phosphorylate the serine residue 644 on TSC2, while RSK will phosphorylate serine residue 1798 on TSC2. These phosphorylations will cause the heterodimer to fall apart, and prevent it from deactivating Rheb, which keeps mTORC1 active.
1366:
molecule, allowing this protein to dock on the FRB regulatory region (FKBP12-Rapamycin
Binding region/domain) on mTORC1. The binding of the FKBP12-rapamycin complex to the FRB regulatory region inhibits mTORC1 through processes not yet known.
725:
is responsible for cellular growth and proliferation during organismal development; thus, it could be reasoned that activation of this pathway also activates mTORC1. Activation of the Wnt pathway inhibits glycogen synthase kinase 3 beta
1378:
and is not very stable, so scientists developed rapamycin analogs, called rapalogs, to overcome these two problems with rapamycin. These drugs are considered the first generation inhibitors of mTOR. These other inhibitors include
993:
pathway. In addition, amino acid consumption will stimulate mTORC1 through the branched chain amino acid/Rag pathway. Thus dietary restriction inhibits mTORC1 signaling through both upstream pathways of mTORC that converge on the
1462:
via phosphorylation. When this negative feedback loop is no longer there, the upstream regulators of mTORC1 become more active than they would otherwise would have been under normal mTORC1 activity. Another problem is that since
1025:. Thus, autophagy is a way for the cell to recycle old and damaged materials by breaking them down into their smaller components, allowing for the resynthesis of newer and healthier cellular structures. Autophagy can thus remove
817:. After translation, this REDD1 protein will bind to TSC2, which prevents 14-3-3 from inhibiting the TSC complex. Thus, TSC retains its GAP activity towards Rheb, causing Rheb to remain bound to GDP and mTORC1 to be inactive.
781:
AMPK can phosphorylate TSC2 on serine residue 1387, which activates the GAP activity of this complex, causing Rheb-GTP to be hydrolyzed into Rheb-GDP. This inactivates mTORC1 and blocks protein synthesis through this pathway.
954:
S6K1 can also participate in a positive feedback loop with mTORC1 by phosphorylating mTOR's negative regulatory domain at two sites thr-2446 and ser-2448; phosphorylation at these sites appears to stimulate mTOR activity.
708:) signaling pathway essential in stress signaling pathways relating to gene expression, neuronal development, and cell survival. Recent studies have shown there is a direct molecular interaction where JNK phosphorylates
908:
Previous studies suggest that S6K signaling is mediated by mTOR in a rapamycin-dependent manner wherein S6K is displaced from the eIF3 complex upon binding of mTOR with eIF3. Hypophosphorylated S6K is located on the
1495:(PIKK) family of kinases, some second generation inhibitors have dual inhibition towards the mTOR complexes as well as PI3K, which acts upstream of mTORC1. As of 2011, these second generation inhibitors were in
712:
at Ser-696, Thr-706, and Ser-863. Therefore, mTORC1 activity is JNK-dependent. Thus, JNK activation plays a role in protein synthesis via subsequent downstream effectors of mTORC1 such as S6 kinase and eIFs.
488:
mTORC1 signaling to the point where both energy abundance and amino acids are necessary for mTORC1 to function. When amino acids are introduced to a deprived cell, the presence of amino acids causes
989:
Based on upstream signaling of mTORC1, a clear relationship between food consumption and mTORC1 activity has been observed. Most specifically, carbohydrate consumption activates mTORC1 through the
1156:
Though AMPK induced eNOS has been shown to regulate mTORC1 in endothelium. Unlike the other cell type in endothelium eNOS induced mTORC1 and this pathway is required for mitochondrial biogenesis.
1516:, that are more selective for mTORC1 than sirolimus, have been developed and in mice have reduced side effects. mTORC1 inhibitors that have novel mechanisms of action, for example peptides like
1323:. The drug has been found to directly and selectively activate the mTORC1 pathway, including in the mPFC, and to produce rapid-acting antidepressant effects similar to those of ketamine.
753:. IKK beta can phosphorylate TSC1 at serine residue 487 and TSC1 at serine residue 511. This causes the heterodimer TSC complex to fall apart, keeping Rheb in its active GTP-bound state.
6856:
7141:
381:. This complex embodies the classic functions of mTOR, namely as a nutrient/energy/redox sensor and controller of protein synthesis. The activity of this complex is regulated by
1068:, a cytosolic lectin, which recognizes damaged lysosomal membranes by binding to the exposed glycoconjugates normally facing lysosomal lumen. Under homeostatic conditions,
982:, doubling its lifespan. This greatly increased the interest in upstream signaling and mTORC1. Studies in inhibiting mTORC1 were thus performed on the model organisms of
1491:
on the kinase domain of the mTOR core protein itself and abolish activity of both mTOR complexes. In addition, since the mTOR and the PI3K proteins are both in the same
1193:
Rapamycin is used clinically as an immunosuppressant and prevents the proliferation of T cells and B cells. Paradoxically, even though rapamycin is a federally approved
6295:Śledź KM, Moore SF, Durrant TN, et al. (July 2020). "Rapamycin restrains platelet procoagulant responses via FKBP-mediated protection of mitochondrial integrity".
1362:
was the first known inhibitor of mTORC1, considering that mTORC1 was discovered as being the target of rapamycin. Rapamycin will bind to cytosolic FKBP12 and act as a
5487:
Miwa S, Sugimoto N, Yamamoto N, et al. (September 2012). "Caffeine induces apoptosis of osteosarcoma cells by inhibiting AKT/mTOR/S6K, NF-κB and MAPK pathways".
4777:
Adam-Vizi V (2005). "Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources".
820:
Due to the lack of synthesis of ATP in the mitochondria under hypoxic stress or hypoxia, AMPK will also become active and thus inhibit mTORC1 through its processes.
595:
Akt will also phosphorylate PRAS40, causing it to fall off of the Raptor protein located on mTORC1. Since PRAS40 prevents Raptor from recruiting mTORC1's substrates
5795:
De P, Miskimins K, Dey N, et al. (August 2013). "Promise of rapalogues versus mTOR kinase inhibitors in subset specific breast cancer: old targets new hope".
587:
phosphorylates TSC2 on serine residue 939, serine residue 981, and threonine residue 1462. These phosphorylated sites will recruit the cytosolic anchoring protein
1052:
promote longevity in humans. Problems in proper autophagy processes have been linked to diabetes, cardiovascular disease, neurodegenerative diseases, and cancer.
6849:
6248:"Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes"
6416:
Lv X, Ma X, Hu Y (August 2013). "Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment".
1209:
that become mature T cells during the contraction phase of their development. mTORC1 inhibition with rapamycin has also been linked to a dramatic increase of
3396:
Wang H, Zhang Q, Wen Q, et al. (January 2012). "Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway".
4137:
Kaeberlein M, Powers RW, Steffen KK, et al. (November 2005). "Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients".
6842:
1371:
is also inhibited by rapamycin in some cell culture lines and tissues, particularly those that express high levels of FKBP12 and low levels of FKBP51.
7049:
6373:
Zask A, Verheijen JC, Richard DJ (July 2011). "Recent advances in the discovery of small-molecule ATP competitive mTOR inhibitors: a patent review".
5930:"Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature"
2762:"Osmotic stress regulates mammalian target of rapamycin (mTOR) complex 1 via c-Jun N-terminal Kinase (JNK)-mediated Raptor protein phosphorylation"
1183:
development. Treating stem cells with rapamycin will also slow their proliferation, conserving the stem cells in their undifferentiated condition.
227:
66:
3552:"mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events"
8394:
1072:
associates with active mTOR. Following membrane damage galectin-8 no longer interacts with mTOR but instead switches to complexes containing
2256:
Saucedo LJ, Gao X, Chiarelli DA, et al. (June 2003). "Rheb promotes cell growth as a component of the insulin/TOR signalling network".
492:
heterodimers to switch to their active conformation. Active Rag heterodimers interact with raptor, localizing mTORC1 to the surface of late
8436:
7597:
6900:
1492:
2607:"Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance"
8545:
3149:"Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis"
1663:"GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR"
928:. Active S6K1 can in turn stimulate the initiation of protein synthesis through activation of S6 Ribosomal protein (a component of the
7283:
7170:
888:, which prevent premature translation of proteins. Once the initiation complex is assembled at the 5' cap of mRNA, it will recruit the
439:
Almost all of the variables required for protein synthesis affect mTORC1 activation by interacting with the TSC1/TSC2 protein complex.
5516:"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle"
4814:"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth"
1754:
Fang Y, Vilella-Bach M, Bachmann R, et al. (November 2001). "Phosphatidic acid-mediated mitogenic activation of mTOR signaling".
414:
adequate energy resources, nutrient availability, oxygen abundance, and proper growth factors in order for mRNA translation to begin.
7558:
1537:
8531:
8350:
7996:
7592:
7582:
7577:
6887:
6869:
4730:"Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression"
2854:"Inhibition of protein synthesis and JNK activation are not required for cell death induced by anisomycin and anisomycin analogues"
1517:
8633:
8514:
1513:
670:
657:
group and is in its inactive GDP state. Upon growth factor binding to the adjacent receptor tyrosine kinase, the adaptor protein
538:
534:
530:
4971:"Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine"
4090:"The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later life"
805:
When oxygen levels in the cell are low, it will limit its energy expenditure through the inhibition of protein synthesis. Under
8220:
7089:
674:
232:
3931:
Fabrizio P, Pozza F, Pletcher SD, et al. (April 2001). "Regulation of longevity and stress resistance by Sch9 in yeast".
71:
9018:
8284:
7259:
6537:
9013:
8540:
5072:"Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development"
2507:"The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1"
1258:
in skeletal muscle cells that result in mTOR phosphorylation, the activation of mTORC1, and subsequently the initiation of
1251:
910:
913:
scaffold complex. Active mTORC1 gets recruited to the scaffold, and once there, will phosphorylate S6K to make it active.
7074:
403:
251:
90:
5832:"Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system"
4922:"Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling"
2656:"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis"
970:). PDCD4 is a tumor suppressor that binds to eIF4A and prevents it from being incorporated into the initiation complex.
8272:
1319:, a leucine amino acid sensor and upstream regulatory pathway of mTORC1, and is under development for the treatment of
8597:
1221:
of rapamycin inhibiting the immune system response has been linked to several reasons, including its interaction with
1172:. mTORC1 activity plays a critical role in the growth and proliferation of stem cells. Knocking out mTORC1 results in
8712:
7529:
7519:
7204:
2853:
6834:
3700:
Pullen N, Dennis PB, Andjelkovic M, et al. (January 1998). "Phosphorylation and activation of p70s6k by PDK1".
410:. Recently it has been also demonstrated that cellular bicarbonate metabolism can be regulated by mTORC1 signaling.
8211:
3601:"Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site"
1205:
during the expansion phase of T cell development . This inhibition also allows for an increase in quality of these
705:
239:
78:
8480:
8152:
7514:
7505:
876:
eukaryotic translation initiation factor A (eIF4A) and its cofactor eukaryotic translation initiation factor 4B (
1044:, Atg17, and Atg101. This prevents the structure from being recruited to the preautophagosomal structure at the
797:
that can activate AMPK. More studies on this aspect of mTORC1 may help shed light on its strong link to cancer.
9033:
2350:"A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1"
1396:
4269:"Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease"
1064:
and is inhibited when lysosomal membrane is damaged through a protein complex termed GALTOR. GALTOR contains
8868:
7895:
7392:
7383:
7040:
6986:
2878:
614:
elevation in the blood, its signaling ensures that there is energy for protein synthesis to take place. In a
362:
51:
24:
3357:"Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway"
7083:
1614:"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery"
1410:
1033:
775:
951:
has been spliced out. Once S6K binds to this complex, increased translation on these mRNA regions occurs.
770:, need to be present. If these levels of ATP are not present, due to its hydrolysis into other forms like
244:
5694:"Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins"
5559:, et al. (February 2007). "Targeting mammalian target of rapamycin (mTOR) for health and diseases".
4636:
Apel K, Hirt H (2004). "Reactive oxygen species: metabolism, oxidative stress, and signal transduction".
1496:
1331:
There have been several dietary compounds that have been suggested to inhibit mTORC1 signaling including
1300:
900:
has been degraded by the eIF4A helicase. Once the ribosome reaches the AUG codon, translation can begin.
746:
603:, its removal will allow the two substrates to be recruited to mTORC1 and thereby activated in this way.
83:
3259:"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex"
3006:
Hardie DG (October 2007). "AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy".
2813:"JNK signaling promotes intestinal tumorigenesis through activation of mTOR complex 1 in Apc(Δ716) mice"
9023:
8983:
8107:
7925:
7421:
6726:"Discovery of Small-Molecule Selective mTORC1 Inhibitors via Direct Inhibition of Glucose Transporters"
6338:
Schenone S, Brullo C, Musumeci F, et al. (2011). "ATP-competitive inhibitors of mTOR: an update".
1807:"Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance"
881:
778:
will become activated. AMPK will go on to inhibit energy consuming pathways such as protein synthesis.
3892:"Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase"
3515:
Lee T, Pelletier J (January 2012). "Eukaryotic initiation factor 4F: a vulnerability of tumor cells".
2705:"Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation"
1395:
complex. mTORC1 inhibition by everolimus has been shown to normalize tumor blood vessels, to increase
1153:
response elements as well as antioxidants in response to increased levels of reactive oxygen species.
509:
Rag activity is regulated by at least two highly conserved complexes: the "GATOR1" complex containing
8969:
8956:
8943:
8930:
8917:
8904:
8891:
8853:
8097:
8092:
8087:
8077:
8072:
8067:
8057:
7852:
7627:
7223:
3802:"SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs"
1135:
580:
542:
448:
8863:
8817:
8760:
8320:
8311:
8262:
7028:
6873:
6828:
6824:
5387:"Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide"
1459:
1292:
1285:
1187:
1127:
701:
576:
131:
9038:
8765:
8620:
8043:
3851:"Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase"
1108:
771:
5023:"mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells"
4190:"Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans)"
766:
In order for translation to take place, abundant sources of energy, particularly in the form of
6077:
Smith SM (June 2012). "Targeting mTOR in mantle cell lymphoma: current and future directions".
4318:"Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks"
2957:"Context-Dependent Regulation of Autophagy by IKK-NF-κB Signaling: Impact on the Aging Process"
1455:
1418:
1400:
1100:
and starts a quality control program that removes damaged lysosomes, referred to as lysophagy,
767:
615:
456:
6517:
6461:"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity"
5637:"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity"
1858:"The mTORC1-SLC4A7 axis stimulates bicarbonate import to enhance de novo nucleotide synthesis"
8786:
8705:
7319:
4649:
1308:
1201:. mTORC1 inhibition with rapamycin improves the ability of naïve T cells to become precursor
1089:
990:
978:
mTOR was found to be related to aging in 2001 when the ortholog of S6K, SCH9, was deleted in
940:
484:
478:
297:
1524:(Rheb inhibitor NR1), which inhibit the interaction of mTORC1 with its endogenous activator
301:
8858:
7886:
6778:
6680:
6623:
6566:
6472:
5648:
5284:
4825:
4146:
4044:
3940:
3756:
3709:
3656:
3211:
2716:
2410:
Ma XM, Blenis J (May 2009). "Molecular mechanisms of mTOR-mediated translational control".
2361:
2212:
1763:
1434:
1430:
1414:
1119:
731:
148:
136:
5438:"Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR"
321:
172:
8:
8822:
7995:
4284:
3984:"TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO"
3200:"Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis"
1529:
1429:. In 2007, mTORC1 inhibitors began being approved for treatments against cancers such as
1391:, everolimus is more selective for the mTORC1 protein complex, with little impact on the
1238:
1093:
678:
152:
6886:
6782:
6684:
6627:
6570:
6476:
5652:
5288:
4829:
4150:
4048:
3944:
3760:
3713:
3660:
3215:
2720:
2365:
2216:
1767:
9028:
8755:
8497:
8451:
6799:
6766:
6701:
6668:
6644:
6611:
6587:
6554:
6493:
6460:
6441:
6398:
6320:
6272:
6247:
6223:
6198:
6176:
6054:
6029:
6005:
5978:
5959:
5905:
5880:
5856:
5831:
5772:
5747:
5718:
5693:
5669:
5636:
5464:
5437:
5413:
5386:
5357:
5332:
5305:
5272:
5248:
5221:
5197:
5172:
5148:
5123:
4995:
4970:
4946:
4921:
4897:
4872:
4848:
4813:
4754:
4729:
4705:
4680:
4661:
4572:
4547:
4439:
4391:
4366:
4342:
4317:
4293:
4268:
4170:
4119:
4065:
4032:
4008:
3983:
3964:
3831:
3782:
3682:
3581:
3492:
3467:
3431:
Raught B, Gingras AC (January 1999). "eIF4E activity is regulated at multiple levels".
3332:
3307:
3234:
3199:
3175:
3148:
3124:
3099:
3075:
3050:
3031:
2983:
2956:
2932:
2905:
2788:
2761:
2742:
2685:
2631:
2606:
2582:
2557:
2533:
2506:
2482:
2457:
2435:
2382:
2349:
2325:
2300:
2281:
2233:
2200:
2176:
2151:
2127:
2094:
2070:
2045:
2021:
1996:
1931:
1906:
1882:
1857:
1833:
1806:
1787:
1736:
1643:
1442:
1312:
1278:
1222:
1026:
627:
422:
5096:
5071:
5047:
5022:
4232:
Choi AM, Ryter SW, Levine B (February 2013). "Autophagy in human health and disease".
3769:
3744:
3669:
3644:
3444:
3283:
3258:
1679:
1662:
1630:
1613:
1543:
There have been over 1,300 clinical trials conducted with mTOR inhibitors since 1970.
268:
7757:
7466:
6864:
6804:
6747:
6706:
6649:
6592:
6533:
6498:
6433:
6402:
6390:
6355:
6324:
6312:
6277:
6228:
6168:
6129:
6094:
6059:
6010:
5951:
5910:
5861:
5812:
5777:
5723:
5674:
5617:
5576:
5537:
5496:
5469:
5418:
5362:
5348:
5310:
5253:
5202:
5153:
5101:
5087:
5052:
5038:
5000:
4951:
4902:
4853:
4794:
4759:
4710:
4653:
4618:
4577:
4521:
4480:
4431:
4396:
4347:
4298:
4249:
4211:
4162:
4123:
4111:
4070:
4013:
3956:
3913:
3872:
3823:
3774:
3725:
3674:
3622:
3573:
3532:
3497:
3448:
3413:
3378:
3337:
3288:
3239:
3180:
3129:
3080:
3023:
2988:
2937:
2883:
2834:
2793:
2734:
2677:
2636:
2587:
2538:
2487:
2427:
2387:
2330:
2273:
2238:
2181:
2132:
2075:
2026:
1977:
1936:
1887:
1838:
1779:
1728:
1684:
1635:
1587:
1488:
1438:
1320:
1262:
1255:
1194:
1123:
806:
665:. This recruits the GEF called Sos, which activates the Ras G protein. Ras activates
623:
386:
6445:
6180:
5963:
4665:
4443:
4174:
3968:
3835:
3686:
3585:
3035:
2746:
2689:
2439:
2285:
1791:
1740:
8801:
8796:
8770:
8698:
7495:
7486:
7416:
7407:
7353:
7344:
7001:
6794:
6786:
6742:
6737:
6725:
6696:
6688:
6639:
6631:
6582:
6574:
6529:
6525:
6488:
6480:
6425:
6382:
6347:
6304:
6267:
6259:
6218:
6210:
6160:
6121:
6086:
6049:
6041:
6000:
5990:
5941:
5900:
5892:
5851:
5843:
5804:
5767:
5759:
5713:
5705:
5664:
5656:
5607:
5568:
5527:
5459:
5449:
5408:
5403:
5398:
5352:
5344:
5300:
5292:
5243:
5233:
5192:
5184:
5143:
5135:
5091:
5083:
5042:
5034:
4990:
4982:
4941:
4933:
4892:
4884:
4843:
4833:
4786:
4749:
4741:
4700:
4692:
4645:
4608:
4567:
4559:
4511:
4470:
4423:
4386:
4378:
4337:
4329:
4288:
4280:
4241:
4201:
4154:
4101:
4060:
4052:
4003:
3995:
3948:
3903:
3862:
3813:
3786:
3764:
3717:
3664:
3612:
3563:
3524:
3487:
3479:
3440:
3405:
3368:
3327:
3319:
3278:
3270:
3229:
3219:
3170:
3160:
3119:
3111:
3070:
3062:
3015:
2978:
2968:
2927:
2917:
2873:
2865:
2824:
2783:
2773:
2724:
2667:
2626:
2618:
2577:
2569:
2528:
2518:
2477:
2469:
2419:
2377:
2369:
2320:
2312:
2265:
2228:
2220:
2171:
2163:
2122:
2114:
2106:
2065:
2057:
2016:
2008:
1967:
1926:
1922:
1918:
1877:
1869:
1828:
1818:
1771:
1718:
1674:
1647:
1625:
1577:
1149:) gene, which is a transcription factor that is able to regulate the expression of
1010:
963:
936:
794:
649:, which can inhibit the TSC1/TSC2 complex, activating mTORC1. In this pathway, the
646:
619:
407:
292:
143:
5763:
4414:
Proud CG (November 2007). "Amino acids and mTOR signalling in anabolic function".
3409:
920:
S6K1 on at least two residues, with the most critical modification occurring on a
8848:
8832:
8745:
8176:
7247:
7242:
7237:
6429:
6386:
6214:
6149:"Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition"
5612:
5595:
5572:
5173:"An emerging role for TOR signaling in mammalian tissue and stem cell physiology"
4563:
4106:
4089:
3721:
3115:
2829:
2812:
2167:
2110:
1873:
1500:
1045:
837:
469:
through activation or inactivation of the TSC1/TSC2 complex, upstream of mTORC1.
465:
358:
that functions as a nutrient/energy/redox sensor and controls protein synthesis.
355:
107:
5946:
5929:
5124:"mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells"
4613:
4596:
1197:, its inhibition of mTORC1 results in better quantity and quality of functional
924:
residue (T389). This event stimulates the subsequent phosphorylation of S6K1 by
331:
182:
8997:
8886:
8827:
6692:
6578:
6351:
6164:
6125:
6090:
5896:
5808:
5748:"Pushing the envelope in the mTOR pathway: the second generation of inhibitors"
5532:
5515:
4937:
4818:
Proceedings of the
National Academy of Sciences of the United States of America
4745:
4033:"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice"
3999:
3818:
3801:
3568:
3551:
3204:
Proceedings of the
National Academy of Sciences of the United States of America
3051:"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism"
2869:
2672:
2655:
2473:
1723:
1706:
1472:, which are not produced by structurally unrelated inhibitors of mTORC such as
1348:
1214:
1206:
1202:
1198:
1018:
6308:
6045:
5881:"Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity"
5139:
4382:
2906:"Wnt signaling pathways in urological cancers: past decades and still growing"
2851:
2729:
2704:
2573:
1823:
864:). eIF4E is now free to join the eukaryotic translation initiation factor 4G (
9007:
8791:
8750:
7232:
5238:
4986:
1426:
1375:
1150:
917:
836:
mTORC1 activates transcription and translation through its interactions with
7300:
6484:
6199:"Targeting the mTOR kinase domain: the second generation of mTOR inhibitors"
5660:
5454:
4838:
4790:
4158:
3952:
3308:"AMP-activated protein kinase, stress responses and cardiovascular diseases"
3224:
2778:
2622:
2373:
2224:
1775:
8740:
8171:
6996:
6808:
6751:
6710:
6653:
6596:
6502:
6437:
6394:
6359:
6316:
6281:
6232:
6172:
6133:
6112:
Fasolo A, Sessa C (2012). "Targeting mTOR pathways in human malignancies".
6098:
6063:
6014:
5955:
5914:
5865:
5816:
5781:
5727:
5678:
5621:
5580:
5500:
5473:
5422:
5366:
5314:
5257:
5206:
5157:
5105:
5056:
5004:
4955:
4906:
4857:
4798:
4763:
4714:
4657:
4622:
4581:
4525:
4516:
4499:
4484:
4475:
4458:
4435:
4400:
4351:
4302:
4253:
4215:
4166:
4115:
4074:
4017:
3960:
3917:
3908:
3891:
3876:
3867:
3850:
3827:
3626:
3617:
3600:
3577:
3536:
3501:
3452:
3417:
3382:
3341:
3292:
3243:
3184:
3133:
3084:
3027:
2992:
2941:
2922:
2887:
2838:
2797:
2738:
2681:
2640:
2591:
2542:
2523:
2491:
2431:
2391:
2334:
2277:
2242:
2185:
2136:
2079:
2030:
2012:
1981:
1940:
1891:
1842:
1783:
1732:
1688:
1639:
1591:
1384:
1112:
897:
5541:
4245:
3778:
3729:
3678:
2973:
2316:
1141:
Inhibition of mTORC1 has also been shown to increase transcription of the
1111:
can damage the DNA and proteins in cells. A majority of them arise in the
8964:
8899:
8735:
8377:
8009:
7949:
7832:
7752:
7476:
6669:"A small molecule inhibitor of Rheb selectively targets mTORC1 signaling"
6263:
4333:
4206:
4189:
3981:
2118:
1972:
1955:
1473:
1336:
1180:
967:
932:) and eIF4B, causing them to be recruited to the pre-initiation complex.
893:
860:, thereby releasing it from eukaryotic translation initiation factor 4E (
722:
557:
461:
390:
280:
119:
6790:
6635:
6518:"Role of mTOR signaling in tumor cell motility, invasion and metastasis"
5995:
5296:
4056:
3483:
3373:
3356:
3274:
2301:"Spatial regulation of the mTORC1 system in amino acids sensing pathway"
2201:"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1"
1582:
1565:
8465:
6939:
5847:
5709:
5188:
4696:
4427:
3528:
3323:
1380:
1165:
1131:
1069:
1065:
1014:
828:
666:
662:
650:
622:
and inhibit its sensitivity to insulin. This has great significance in
607:
275:
114:
3982:
Robida-Stubbs S, Glover-Cutter K, Lamming DW, et al. (May 2012).
880:). The helicase is required to remove hairpin loops that arise in the
872:). This complex then binds to the 5' cap of mRNA and will recruit the
606:
Furthermore, since insulin is a factor that is secreted by pancreatic
8938:
8912:
7426:
5556:
4500:"Autophagy and signaling: their role in cell survival and cell death"
2852:
Monaghan D, O'Connell E, Cruickshank FL, et al. (January 2014).
1521:
1406:
1388:
1359:
1259:
1176:
1097:
1022:
1006:
921:
749:(TNF-alpha) can induce mTOR activity through IKK beta, also known as
742:
382:
5596:"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB"
4888:
3165:
3066:
3019:
2954:
2423:
2348:
Bar-Peled L, Chantranupong L, Cherniack AD, et al. (May 2013).
2061:
1021:
or proteins and smaller cellular debris via microautophagy from the
892:
small ribosomal subunit that is now capable of scanning for the AUG
813:) will stabilize and activate transcription of REDD1, also known as
8992:
7782:
7677:
7672:
7667:
6148:
5830:
Arriola Apelo SI, Neuman JC, Baar EL, et al. (February 2016).
4728:
Bonawitz ND, Chatenay-Lapointe M, Pan Y, et al. (April 2007).
2605:
McCubrey JA, Steelman LS, Chappell WH, et al. (October 2012).
2347:
2269:
1363:
1344:
1340:
1316:
1288:
1061:
995:
929:
873:
654:
497:
493:
427:
369:(commonly known as raptor), mammalian lethal with SEC13 protein 8 (
7142:
3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring) kinase
6612:"Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40"
4873:"NRF2 and cancer: the good, the bad and the importance of context"
4727:
3147:
Nagalingam A, Arbiser JL, Bonner MY, et al. (February 2012).
2703:
Carrière A, Cargnello M, Julien LA, et al. (September 2008).
856:
Activated mTORC1 will phosphorylate translation repressor protein
8441:
8419:
8414:
8404:
8399:
8201:
8196:
8191:
8186:
8181:
8166:
8161:
7812:
7777:
7016:
7011:
7006:
6555:"A novel rapamycin analog is highly selective for mTORC1 in vivo"
3355:
Martelli AM, Evangelisti C, Chappell W, et al. (July 2011).
3354:
3198:
Horak P, Crawford AR, Vadysirisack DD, et al. (March 2010).
2458:"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation"
1533:
1477:
1437:. mTORC1 inhibitors have recently been approved for treatment of
1409:, which is the drug name for rapamycin, was approved by the U.S.
1304:
1242:
1218:
1210:
1085:
1073:
638:
611:
394:
6552:
3100:"AMPK phosphorylation of raptor mediates a metabolic checkpoint"
1753:
1186:
mTORC1 plays a role in the differentiation and proliferation of
256:
95:
8951:
8721:
8671:
8666:
8661:
8656:
8651:
8646:
8641:
8592:
8587:
8582:
8577:
8572:
8555:
8550:
8424:
8409:
8360:
8355:
8340:
8335:
8330:
8325:
8299:
8294:
8289:
8277:
8255:
8250:
8142:
8117:
7792:
7617:
7612:
7607:
7602:
7587:
7431:
7368:
7363:
7358:
7334:
7160:
7155:
7129:
7124:
7119:
7109:
7104:
7094:
6934:
6865:
6553:
Schreiber KH, Arriola Apelo SI, Yu D, et al. (July 2019).
4594:
4316:
Alers S, Löffler AS, Wesselborg S, et al. (January 2012).
1481:
1469:
1464:
1392:
1368:
1266:
1173:
1142:
948:
857:
841:
689:
596:
588:
546:
510:
444:
378:
374:
263:
102:
5692:
Schreiber KH, Ortiz D, Academia EC, et al. (April 2015).
5070:
Gangloff YG, Mueller M, Dann SG, et al. (November 2004).
4136:
3468:"Control of mammalian translation by mRNA structure near caps"
2604:
2504:
1905:
Sharma A, Hoeffer CA, Takayasu Y, et al. (January 2010).
1029:
and damaged organelles that can lead to cellular dysfunction.
545:
for Rag subunits A/B) and GATOR2 activates Rags by inhibiting
8925:
8567:
8560:
8470:
8367:
8267:
8245:
8240:
8235:
8230:
8225:
8137:
8132:
8127:
8122:
8112:
8082:
8062:
7939:
7934:
7915:
7910:
7900:
7876:
7871:
7866:
7842:
7837:
7827:
7822:
7817:
7807:
7787:
7772:
7767:
7762:
7742:
7737:
7727:
7722:
7717:
7712:
7707:
7697:
7692:
7687:
7682:
7662:
7657:
7652:
7647:
7642:
7637:
7622:
7572:
7567:
7461:
7456:
7451:
7446:
7441:
7436:
7397:
7329:
7324:
7273:
7268:
7194:
7189:
7184:
7150:
6944:
6929:
6924:
6919:
6914:
6909:
6724:
Kang SA, O'Neill DJ, Machl AW, et al. (September 2019).
3699:
3466:
Babendure JR, Babendure JL, Ding JH, et al. (May 2006).
3257:
Brugarolas J, Lei K, Hurley RL, et al. (December 2004).
3197:
3146:
3098:
Gwinn DM, Shackelford DB, Egan DF, et al. (April 2008).
3097:
2654:
Ma L, Chen Z, Erdjument-Bromage H, et al. (April 2005).
2653:
1904:
1422:
1299:
as an essential downstream mechanism in the mediation of its
1296:
1274:
1270:
1169:
1168:
in the body has been shown to help prevent against premature
1081:
1077:
959:
944:
925:
877:
869:
865:
861:
845:
814:
810:
790:
727:
709:
704:) signaling is part of the mitogen-activated protein kinase (
685:
526:
518:
514:
370:
366:
212:
197:
6764:
6667:
Mahoney SJ, Narayan S, Molz L, et al. (February 2018).
6246:
Veilleux A, Houde VP, Bellmann K, et al. (April 2010).
6245:
5594:
Sarbassov DD, Ali SM, Sengupta S, et al. (April 2006).
5021:
Murakami M, Ichisaka T, Maeda M, et al. (August 2004).
4595:
Hasegawa J, Maejima I, Iwamoto R, et al. (March 2015).
4546:
Jia J, Abudu YP, Claude-Taupin A, et al. (April 2018).
3930:
3433:
2198:
575:
Insulin-like growth factors can activate mTORC1 through the
8460:
8387:
8382:
8372:
8345:
8102:
8052:
8033:
8028:
8023:
8018:
7973:
7968:
7963:
7958:
7905:
7861:
7802:
7797:
7747:
7732:
7702:
7632:
7548:
7543:
7538:
7471:
7373:
7314:
7309:
7213:
7179:
7064:
7059:
7054:
7023:
6991:
6979:
6974:
6969:
6959:
6954:
6767:"mTOR is a key modulator of ageing and age-related disease"
6723:
6458:
5829:
5794:
5691:
5634:
5020:
4548:"Galectins Control mTOR in Response to Endomembrane Damage"
4315:
3745:"Translation control: connecting mitogens and the ribosome"
3598:
3465:
2505:
Oshiro N, Takahashi R, Yoshino K, et al. (July 2007).
1525:
1332:
1041:
1037:
885:
750:
658:
642:
600:
522:
452:
440:
8690:
6666:
6337:
5745:
5486:
5270:
5069:
4031:
Harrison DE, Strong R, Sharp ZD, et al. (July 2009).
3550:
Holz MK, Ballif BA, Gygi SP, et al. (November 2005).
3256:
2955:
Salminen A, Hyttinen JM, Kauppinen A, et al. (2012).
2702:
2199:
Sancak Y, Peterson TR, Shaul YD, et al. (June 2008).
1855:
943:). Exon junction complexes span the mRNA region where two
504:
8429:
6964:
6949:
6765:
Johnson SC, Rabinovitch PS, Kaeberlein M (January 2013).
6459:
Lamming DW, Ye L, Katajisto P, et al. (March 2012).
5635:
Lamming DW, Ye L, Katajisto P, et al. (March 2012).
5593:
5271:
Araki K, Turner AP, Shaffer VO, et al. (July 2009).
4030:
3800:
Ma XM, Yoon SO, Richardson CJ, et al. (April 2008).
1956:"The evolution of the TOR pathway and its role in cancer"
1425:
covering for widening arteries to prevent against future
889:
584:
8619:
5979:"Everolimus-eluting stents in interventional cardiology"
5976:
5879:
Wang S, Raybuck A, Shiuan E, et al. (August 2020).
1811:
1661:
Kim DH, Sarbassov DD, Ali SM, et al. (April 2003).
5333:"The role of mTOR in memory CD8 T-cell differentiation"
5222:"Akt and mTOR in B Cell Activation and Differentiation"
4545:
3599:
Saitoh M, Pullen N, Brennan P, et al. (May 2002).
1907:"Dysregulation of mTOR signaling in fragile X syndrome"
1704:
1612:
Kim DH, Sarbassov DD, Ali SM, et al. (July 2002).
868:) and the eukaryotic translation initiation factor 4A (
774:, and the ratio of AMP to ATP molecules gets too high,
618:
on mTORC1 signaling, S6K1 is able to phosphorylate the
32:
6294:
3799:
3645:"The modular phosphorylation and activation of p70s6k"
1856:
Ali E, Liponska A, O'Hara B, et al. (June 2022).
1798:
1458:
from phosphorylated S6K, that can inhibit the insulin
1134:
in the cytosol for ATP production rather than through
451:). Its GAP activity interacts with a G protein called
8981:
5436:
Liu M, Wilk SA, Wang A, et al. (November 2010).
4459:"Age-related decline in chaperone-mediated autophagy"
4088:
Lynn MA, Eden G, Ryan FJ, et al. (August 2021).
2255:
1487:
Second generation inhibitors are able to bind to the
1291:
has been found to activate the mTORC1 pathway in the
6610:
Yang H, Jiang X, Li B, et al. (December 2017).
6372:
5878:
5513:
5330:
4087:
3549:
1705:
Wullschleger S, Loewith R, Hall MN (February 2006).
1660:
1122:
in the mitochondria by enhancing the translation of
958:
S6K also can phosphorylate programmed cell death 4 (
688:, which helps it overcome the inhibitory effects of
5746:Vilar E, Perez-Garcia J, Tabernero J (March 2011).
5122:Chen C, Liu Y, Liu Y, et al. (November 2009).
2858:
2810:
2152:"Amino acids and mTORC1: from lysosomes to disease"
2149:
2095:"Amino acids and mTORC1: from lysosomes to disease"
2092:
1611:
939:
that can get recruited to exon junction complexes (
6079:Best Practice & Research. Clinical Haematology
6030:"mTOR inhibitors in advanced renal cell carcinoma"
5273:"mTOR regulates memory CD8 T-cell differentiation"
4968:
4920:Li C, Reif MM, Craige SM, et al. (May 2016).
4681:"How mitochondria produce reactive oxygen species"
1953:
3742:
3395:
2879:20.500.11820/ba05d42b-8452-4391-8c4a-c2850cb28b12
2760:Kwak D, Choi S, Jeong H, et al. (May 2012).
2759:
2150:Efeyan A, Zoncu R, Sabatini DM (September 2012).
2093:Efeyan A, Zoncu R, Sabatini DM (September 2012).
2043:
9005:
6027:
5514:Vézina C, Kudelski A, Sehgal SN (October 1975).
4919:
4913:
2903:
2405:
2403:
2401:
809:conditions, hypoxia inducible factor one alpha (
6609:
6192:
6190:
5741:
5739:
5737:
5554:
5435:
5380:
5378:
5376:
5326:
5324:
5170:
5121:
5117:
5115:
5016:
5014:
4812:Sun Q, Chen X, Ma J, et al. (March 2011).
4231:
4227:
4225:
2899:
2897:
2455:
2451:
2449:
1126:that encodes for the complexes involved in the
6196:
5927:
3638:
3636:
1700:
1698:
1441:. In 2010 they were approved for treatment of
1433:. In 2008 they were approved for treatment of
8706:
6901:Non-specific serine/threonine protein kinases
6850:
6758:
6717:
6603:
6409:
6366:
6331:
6288:
6028:Voss MH, Molina AM, Motzer RJ (August 2011).
5977:Townsend JC, Rideout P, Steinberg DH (2012).
4811:
4497:
4266:
3883:
3848:
3842:
3793:
3592:
3508:
3430:
3424:
3389:
3348:
3048:
2558:"Mechanisms of insulin resistance in obesity"
2398:
2044:Jewell JL, Russell RC, Guan KL (March 2013).
1118:Deletion of the TOR1 gene in yeast increases
417:
6239:
6187:
6146:
6140:
6105:
6070:
6034:Hematology/Oncology Clinics of North America
6021:
5970:
5921:
5872:
5823:
5788:
5734:
5548:
5480:
5429:
5373:
5321:
5264:
5213:
5164:
5112:
5063:
5011:
4962:
4864:
4805:
4770:
4721:
4672:
4629:
4491:
4450:
4407:
4367:"Molecules and their functions in autophagy"
4358:
4309:
4260:
4222:
4187:
4181:
4130:
4024:
3975:
3924:
3642:
3514:
3299:
3250:
3191:
3140:
3091:
3042:
2999:
2948:
2904:Majid S, Saini S, Dahiya R (February 2012).
2894:
2696:
2647:
2598:
2549:
2498:
2446:
2292:
2249:
2192:
2143:
2037:
1988:
1563:
1493:phosphatidylinositol 3-kinase-related kinase
1013:and is essential for the removal of damaged
973:
565:
472:
464:. This control is usually performed through
6111:
5507:
5331:Araki K, Youngblood B, Ahmed R (May 2010).
5219:
5171:Russell RC, Fang C, Guan KL (August 2011).
4969:Ho AD, Wagner W, Mahlknecht U (July 2005).
4541:
4539:
4537:
4535:
3693:
3633:
3305:
2811:Fujishita T, Aoki M, Taketo MM (May 2011).
2298:
1947:
1695:
1559:
1557:
1555:
1228:
1138:in the inner membrane of the mitochondria.
1032:Upon activation, mTORC1 will phosphorylate
361:mTOR Complex 1 (mTORC1) is composed of the
8713:
8699:
7284:Goodpasture-antigen-binding protein kinase
6857:
6843:
6509:
4456:
4364:
3889:
1954:Beauchamp EM, Platanias LC (August 2013).
1607:
1605:
1603:
1601:
1448:
1265:(i.e., the production of proteins such as
1103:
1036:(Atg 13), preventing it from entering the
7997:Serine/threonine-specific protein kinases
7171:(isocitrate dehydrogenase (NADP+)) kinase
6888:Serine/threonine-specific protein kinases
6870:Serine/threonine-specific protein kinases
6827:at the U.S. National Library of Medicine
6798:
6741:
6700:
6643:
6586:
6515:
6492:
6271:
6222:
6197:Zhang YJ, Duan Y, Zheng XF (April 2011).
6053:
6004:
5994:
5945:
5904:
5855:
5771:
5717:
5668:
5611:
5531:
5463:
5453:
5412:
5402:
5356:
5304:
5247:
5237:
5196:
5147:
5095:
5046:
4994:
4945:
4896:
4870:
4847:
4837:
4776:
4753:
4704:
4612:
4571:
4515:
4474:
4390:
4341:
4292:
4205:
4105:
4064:
4007:
3907:
3866:
3817:
3768:
3736:
3668:
3616:
3567:
3491:
3372:
3331:
3282:
3233:
3223:
3174:
3164:
3123:
3074:
2982:
2972:
2931:
2921:
2877:
2828:
2787:
2777:
2728:
2671:
2630:
2581:
2532:
2522:
2481:
2456:Mendoza MC, Er EE, Blenis J (June 2011).
2381:
2324:
2232:
2175:
2126:
2069:
2020:
1994:
1971:
1930:
1881:
1832:
1822:
1722:
1678:
1629:
1581:
1506:
1354:
684:RSK has also been shown to phosphorylate
653:is tethered to the plasma membrane via a
352:mechanistic target of rapamycin complex 1
8532:Receptor protein serine/threonine kinase
4650:10.1146/annurev.arplant.55.031903.141701
4635:
4532:
4365:Pyo JO, Nah J, Jung YK (February 2012).
3743:Peterson RT, Schreiber SL (March 1998).
3049:Mihaylova MM, Shaw RJ (September 2011).
2409:
2046:"Amino acid signalling upstream of mTOR"
1707:"TOR signaling in growth and metabolism"
1552:
1540:are also selective inhibitors of mTORC1
827:
641:, such as insulin like growth factor 1 (
556:
421:
8515:Low-density-lipoprotein receptor kinase
5928:Nashan B, Citterio F (September 2012).
1598:
823:
505:Regulation of the Ragulator-Rag complex
348:mammalian target of rapamycin complex 1
9006:
6415:
4678:
4498:Codogno P, Meijer AJ (November 2005).
3008:Nature Reviews. Molecular Cell Biology
3005:
2412:Nature Reviews. Molecular Cell Biology
2050:Nature Reviews. Molecular Cell Biology
1654:
8694:
8618:
7994:
7260:Fas-activated serine/threonine kinase
6885:
6838:
6375:Expert Opinion on Therapeutic Patents
6076:
5384:
4413:
4371:Experimental & Molecular Medicine
2961:International Journal of Cell Biology
962:), which marks it for degradation by
832:Receptor Tyrosine Kinases and mTORC1.
552:
521:and the ""GATOR2" complex containing
367:regulatory-associated protein of mTOR
8632:
8541:Bone morphogenetic protein receptors
6147:Budde K, Gaedeke J (February 2012).
4285:10.1146/annurev-pathol-020712-163918
4267:Murrow L, Debnath J (January 2013).
3306:Wang S, Song P, Zou MH (June 2012).
2305:Acta Biochimica et Biophysica Sinica
2299:Suzuki T, Inoki K (September 2011).
1997:"Regulation of TOR by small GTPases"
1804:
1387:. Compared with the parent compound
1252:beta-hydroxy beta-methylbutyric acid
1096:, mTOR inhibition in turn activates
1009:is the major degradation pathway in
756:
7075:Dephospho-(reductase kinase) kinase
6153:American Journal of Kidney Diseases
5983:Vascular Health and Risk Management
5442:The Journal of Biological Chemistry
4463:The Journal of Biological Chemistry
4457:Cuervo AM, Dice JF (October 2000).
4234:The New England Journal of Medicine
3896:The Journal of Biological Chemistry
3855:The Journal of Biological Chemistry
3849:Chiang GG, Abraham RT (July 2005).
3605:The Journal of Biological Chemistry
2766:The Journal of Biological Chemistry
2511:The Journal of Biological Chemistry
1995:Durán RV, Hall MN (February 2012).
1747:
1055:
633:
13:
7530:G-protein coupled receptor kinases
4779:Antioxidants & Redox Signaling
2555:
1564:Hay N, Sonenberg N (August 2004).
1040:kinase complex, which consists of
677:(MAPK). Erk can go on to activate
570:
434:
14:
9050:
7520:Beta adrenergic receptor kinase-2
7205:(tyrosine 3-monooxygenase) kinase
6818:
4188:Blagosklonny MV (February 2010).
1566:"Upstream and downstream of mTOR"
1528:, are also being developed. Some
1413:(FDA) in 1999 to prevent against
800:
8991:
8212:Mitogen-activated protein kinase
6660:
6546:
6524:. Vol. 3. pp. 207–44.
6452:
6418:Expert Opinion on Drug Discovery
5349:10.1111/j.0105-2896.2010.00898.x
5088:10.1128/MCB.24.21.9508-9516.2004
5039:10.1128/MCB.24.15.6710-6718.2004
4597:"Selective autophagy: lysophagy"
4416:Biochemical Society Transactions
3643:Pullen N, Thomas G (June 1997).
1421:. In 2003, it was approved as a
935:Active S6K can bind to the SKAR
761:
541:. GATOR1 inhibits Rags (it is a
31:
8598:Anti-Müllerian hormone receptor
8481:(acetyl-CoA carboxylase) kinase
8153:(RNA-polymerase)-subunit kinase
7515:Beta adrenergic receptor kinase
7506:Beta adrenergic receptor kinase
6522:Advances in Cancer Drug Targets
5685:
5628:
5587:
4871:Sporn MB, Liby KT (July 2012).
4588:
4081:
3890:Holz MK, Blenis J (July 2005).
3543:
3459:
2845:
2804:
2753:
2341:
2086:
846:eukaryotic initiation factor 4E
8221:Extracellular signal-regulated
6743:10.1016/j.chembiol.2019.05.009
6530:10.2174/9781681082332116030009
5404:10.12688/f1000research.14344.1
5076:Molecular and Cellular Biology
5027:Molecular and Cellular Biology
4638:Annual Review of Plant Biology
4504:Cell Death and Differentiation
4322:Molecular and Cellular Biology
2462:Trends in Biochemical Sciences
1923:10.1523/JNEUROSCI.3696-09.2010
1898:
1849:
1401:adoptive cell transfer therapy
1397:tumor-infiltrating lymphocytes
716:
695:
404:β-hydroxy β-methylbutyric acid
1:
8285:P38 mitogen-activated protein
7384:cGMP-dependent protein kinase
7345:cAMP-dependent protein kinase
7041:Pyruvate dehydrogenase kinase
6987:Ataxia telangiectasia mutated
6114:Current Pharmaceutical Design
5764:10.1158/1535-7163.MCT-10-0905
5752:Molecular Cancer Therapeutics
3770:10.1016/S0960-9822(98)70152-6
3670:10.1016/S0014-5793(97)00323-2
3445:10.1016/s1357-2725(98)00131-9
3410:10.1016/j.cellsig.2011.08.010
1680:10.1016/S1097-2765(03)00114-X
1631:10.1016/S0092-8674(02)00808-5
1546:
1374:Rapamycin itself is not very
1326:
1233:
1213:in old mice, enhancing their
1159:
734:for the developing organism.
393:and their derivatives (e.g.,
9019:Genes on human chromosome 17
7084:AMP-activated protein kinase
6430:10.1517/17460441.2013.800479
6387:10.1517/13543776.2011.584871
6215:10.1016/j.drudis.2011.02.008
5613:10.1016/j.molcel.2006.03.029
5573:10.1016/j.drudis.2006.12.008
5220:Limon JJ, Fruman DA (2012).
4564:10.1016/j.molcel.2018.03.009
4107:10.1016/j.celrep.2021.109564
3722:10.1126/science.279.5351.707
3116:10.1016/j.molcel.2008.03.003
2830:10.1053/j.gastro.2011.02.007
2168:10.1016/j.molmed.2012.05.007
2156:Trends in Molecular Medicine
2111:10.1016/j.molmed.2012.05.007
2099:Trends in Molecular Medicine
1874:10.1016/j.molcel.2022.06.008
1411:Food and Drug Administration
1034:autophagy-related protein 13
1001:
737:
426:Activation of mTORC1 at the
7:
9014:Genes on human chromosome 1
8720:
7999:(EC 2.7.11.21-EC 2.7.11.30)
6520:. In Atta-ur-Rahman (ed.).
6340:Current Medicinal Chemistry
5947:10.1097/TP.0b013e3182551021
4614:10.1016/j.ymeth.2014.12.014
1911:The Journal of Neuroscience
1301:rapid-acting antidepressant
747:tumor necrosis factor alpha
561:The General mTORC1 Pathway.
406:), mechanical stimuli, and
385:, insulin, growth factors,
10:
9055:
7926:Elongation factor 2 kinase
6890:(EC 2.7.11.1-EC 2.7.11.20)
6693:10.1038/s41467-018-03035-z
6579:10.1038/s41467-019-11174-0
6352:10.2174/092986711796391651
6165:10.1053/j.ajkd.2011.10.013
6126:10.2174/138161212800626210
6091:10.1016/j.beha.2012.04.008
5897:10.1172/jci.insight.139237
5809:10.1016/j.ctrv.2012.12.002
5533:10.7164/antibiotics.28.721
5520:The Journal of Antibiotics
4938:10.1016/j.niox.2016.03.003
4746:10.1016/j.cmet.2007.02.009
4679:Murphy MP (January 2009).
4273:Annual Review of Pathology
4000:10.1016/j.cmet.2012.04.007
3819:10.1016/j.cell.2008.02.031
3569:10.1016/j.cell.2005.10.024
3517:Future Medicinal Chemistry
2870:10.1016/j.bbrc.2013.12.041
2673:10.1016/j.cell.2005.02.031
2474:10.1016/j.tibs.2011.03.006
1724:10.1016/j.cell.2006.01.016
1254:(HMB) are known to induce
1090:Ragulator) thus inhibiting
669:(MAPKKK), which activates
476:
418:Activation at the lysosome
8877:
8869:Michaelis–Menten kinetics
8841:
8810:
8779:
8728:
8628:
8614:
8530:
8513:
8496:
8479:
8450:
8321:MAP kinase kinase kinases
8310:
8210:
8151:
8042:
8008:
8004:
7990:
7948:
7924:
7885:
7853:Myosin light-chain kinase
7851:
7559:Ca2+/calmodulin-dependent
7557:
7528:
7504:
7485:
7406:
7382:
7343:
7299:
7282:
7258:
7224:Myosin-heavy-chain kinase
7222:
7203:
7169:
7140:
7073:
7039:
6899:
6895:
6881:
6309:10.1016/j.bcp.2020.113975
6046:10.1016/j.hoc.2011.04.008
5140:10.1126/scisignal.2000559
4383:10.3858/emm.2012.44.2.029
2730:10.1016/j.cub.2008.07.078
2574:10.1007/s11684-013-0262-6
1824:10.1186/s12970-016-0118-y
1520:and small molecules like
1136:oxidative phosphorylation
974:Role in disease and aging
851:
700:c-Jun N-terminal kinase (
673:(MAPKK), which activates
581:Akt/PKB signaling pathway
566:Receptor tyrosine kinases
543:GTPase-activating protein
473:The Ragulator-Rag complex
327:
317:
312:
308:
291:
286:
274:
262:
250:
238:
226:
218:
208:
203:
196:
178:
168:
163:
159:
142:
130:
125:
113:
101:
89:
77:
65:
57:
47:
42:
30:
23:
8761:Diffusion-limited enzyme
8621:Dual-specificity kinases
6829:Medical Subject Headings
6516:Zhou H, Huang S (2016).
6297:Biochemical Pharmacology
5797:Cancer Treatment Reviews
5239:10.3389/fimmu.2012.00228
4987:10.1038/sj.embor.7400436
1293:medial prefrontal cortex
1286:NMDA receptor antagonist
1277:), thereby facilitating
1229:As a biomolecular target
1188:hematopoietic stem cells
1128:electron transport chain
1060:mTORC1 is positioned on
1048:, inhibiting autophagy.
896:start site, because the
577:receptor tyrosine kinase
483:mTORC1 interacts at the
8044:Cyclin-dependent kinase
6485:10.1126/science.1215135
6252:Molecular Endocrinology
5661:10.1126/science.1215135
5455:10.1074/jbc.M110.169284
5226:Frontiers in Immunology
4839:10.1073/pnas.1014769108
4791:10.1089/ars.2005.7.1140
4685:The Biochemical Journal
4159:10.1126/science.1115535
3953:10.1126/science.1059497
3263:Genes & Development
3225:10.1073/pnas.0907705107
2779:10.1074/jbc.M111.326538
2623:10.18632/oncotarget.659
2374:10.1126/science.1232044
2225:10.1126/science.1157535
1776:10.1126/science.1066015
1570:Genes & Development
1468:activated immunophilin
1449:Second generation drugs
1417:in patients undergoing
1109:Reactive oxygen species
1104:Reactive oxygen species
947:come together after an
882:5' untranslated regions
37:mTORC1 heteromer, Human
4877:Nature Reviews. Cancer
4517:10.1038/sj.cdd.4401751
4510:(Suppl 2): 1509–1518.
4476:10.1074/jbc.M002102200
3909:10.1074/jbc.M504045200
3868:10.1074/jbc.M501707200
3618:10.1074/jbc.M201745200
3153:Breast Cancer Research
2923:10.1186/1476-4598-11-7
2524:10.1074/jbc.M702636200
2013:10.1038/embor.2011.257
1507:Third generation drugs
1456:negative feedback loop
1419:kidney transplantation
1355:First generation drugs
903:
833:
616:negative feedback loop
562:
431:
9034:Tor signaling pathway
8854:Eadie–Hofstee diagram
8787:Allosteric regulation
6825:mTORC1+complex,+human
6730:Cell Chemical Biology
6673:Nature Communications
6559:Nature Communications
5337:Immunological Reviews
4246:10.1056/NEJMra1205406
2562:Frontiers of Medicine
1805:Bond P (March 2016).
991:insulin growth factor
831:
560:
485:Ragulator-Rag complex
479:Ragulator-Rag complex
425:
8864:Lineweaver–Burk plot
7887:Phosphorylase kinase
6736:(9): 1203–1213.e13.
6264:10.1210/me.2009-0328
6203:Drug Discovery Today
5561:Drug Discovery Today
4981:(Suppl 1): S35–S38.
4334:10.1128/MCB.06159-11
4207:10.4161/cc.9.4.10766
1973:10.1038/onc.2012.567
1435:mantle cell lymphoma
1431:renal cell carcinoma
1415:transplant rejection
1120:cellular respiration
824:Downstream signaling
789:LKB1, also known as
645:), can activate the
447:activating protein (
6791:10.1038/nature11861
6783:2013Natur.493..338J
6685:2018NatCo...9..548M
6636:10.1038/nature25023
6628:2017Natur.552..368Y
6571:2019NatCo..10.3194S
6477:2012Sci...335.1638L
6471:(6076): 1638–1643.
5996:10.2147/VHRM.S23388
5653:2012Sci...335.1638L
5647:(6076): 1638–1643.
5489:Anticancer Research
5448:(47): 36387–36394.
5297:10.1038/nature08155
5289:2009Natur.460..108A
4830:2011PNAS..108.4129S
4785:(9–10): 1140–1149.
4469:(40): 31505–31513.
4422:(Pt 5): 1187–1190.
4151:2005Sci...310.1193K
4145:(5751): 1193–1196.
4057:10.1038/nature08221
4049:2009Natur.460..392H
3945:2001Sci...292..288F
3902:(28): 26089–26093.
3861:(27): 25485–25490.
3761:1998CBio....8.R248P
3714:1998Sci...279..707P
3661:1997FEBSL.410...78P
3611:(22): 20104–20112.
3484:10.1261/rna.2309906
3398:Cellular Signalling
3374:10.1038/leu.2011.46
3275:10.1101/gad.1256804
3216:2010PNAS..107.4675H
3055:Nature Cell Biology
2974:10.1155/2012/849541
2772:(22): 18398–18407.
2721:2008CBio...18.1269C
2556:Ye J (March 2013).
2517:(28): 20329–20339.
2366:2013Sci...340.1100B
2360:(6136): 1100–1106.
2317:10.1093/abbs/gmr066
2258:Nature Cell Biology
2217:2008Sci...320.1496S
2211:(5882): 1496–1501.
1868:(1): 3284–3298.e7.
1768:2001Sci...294.1942F
1762:(5548): 1942–1945.
1583:10.1101/gad.1212704
1532:inhibitors such as
1530:glucose transporter
1239:Resistance exercise
455:by hydrolyzing the
8823:Enzyme superfamily
8756:Enzyme promiscuity
8498:Tropomyosin kinase
8452:Tau-protein kinase
5848:10.1111/acel.12405
5710:10.1111/acel.12313
5189:10.1242/dev.058230
4697:10.1042/BJ20081386
4428:10.1042/BST0351187
3529:10.4155/fmc.11.150
3324:10.1042/CS20110625
1443:tuberous sclerosis
1279:muscle hypertrophy
1256:signaling cascades
1223:regulatory T cells
1027:protein aggregates
834:
628:insulin resistance
626:, which is due to
563:
553:Upstream signaling
432:
61:FRAP, FRAP2, FRAP1
9024:Protein complexes
8979:
8978:
8688:
8687:
8684:
8683:
8680:
8679:
8610:
8609:
8606:
8605:
7986:
7985:
7982:
7981:
7467:Protein kinase N1
7422:Protein kinase Cζ
6777:(7432): 338–345.
6622:(7685): 368–373.
6539:978-1-68108-233-2
6346:(20): 2995–3014.
6120:(19): 2766–2777.
5385:Duman RS (2018).
5283:(7251): 108–112.
5183:(16): 3343–3356.
5128:Science Signaling
5082:(21): 9508–9516.
5033:(15): 6710–6718.
4824:(10): 4129–4134.
4558:(1): 120–135.e8.
4043:(7253): 392–395.
3939:(5515): 288–290.
3708:(5351): 707–710.
3269:(23): 2893–2904.
3210:(10): 4675–4680.
2823:(5): 1556–63.e6.
2715:(17): 1269–1277.
2617:(10): 1068–1111.
1966:(34): 3923–3932.
1576:(16): 1926–1945.
1489:ATP-binding motif
1439:pancreatic cancer
1399:, and to improve
1263:protein synthesis
1241:, the amino acid
1195:immunosuppressant
1124:mitochondrial DNA
757:Energy and oxygen
732:protein synthesis
624:diabetes mellitus
387:phosphatidic acid
365:protein complex,
341:
340:
337:
336:
192:
191:
188:
187:
9046:
8996:
8995:
8987:
8859:Hanes–Woolf plot
8802:Enzyme activator
8797:Enzyme inhibitor
8771:Enzyme catalysis
8715:
8708:
8701:
8692:
8691:
8630:
8629:
8616:
8615:
8263:C-Jun N-terminal
8006:
8005:
7992:
7991:
7496:Rhodopsin kinase
7487:Rhodopsin kinase
7417:Protein kinase C
7408:Protein kinase C
7393:Protein kinase G
7354:Protein kinase A
6965:Protein kinase B
6897:
6896:
6883:
6882:
6859:
6852:
6845:
6836:
6835:
6813:
6812:
6802:
6762:
6756:
6755:
6745:
6721:
6715:
6714:
6704:
6664:
6658:
6657:
6647:
6607:
6601:
6600:
6590:
6550:
6544:
6543:
6513:
6507:
6506:
6496:
6456:
6450:
6449:
6413:
6407:
6406:
6370:
6364:
6363:
6335:
6329:
6328:
6292:
6286:
6285:
6275:
6243:
6237:
6236:
6226:
6209:(7–8): 325–331.
6194:
6185:
6184:
6144:
6138:
6137:
6109:
6103:
6102:
6074:
6068:
6067:
6057:
6025:
6019:
6018:
6008:
5998:
5974:
5968:
5967:
5949:
5925:
5919:
5918:
5908:
5876:
5870:
5869:
5859:
5827:
5821:
5820:
5792:
5786:
5785:
5775:
5743:
5732:
5731:
5721:
5689:
5683:
5682:
5672:
5632:
5626:
5625:
5615:
5591:
5585:
5584:
5567:(3–4): 112–124.
5555:Tsang CK, Qi H,
5552:
5546:
5545:
5535:
5511:
5505:
5504:
5495:(9): 3643–3649.
5484:
5478:
5477:
5467:
5457:
5433:
5427:
5426:
5416:
5406:
5382:
5371:
5370:
5360:
5328:
5319:
5318:
5308:
5268:
5262:
5261:
5251:
5241:
5217:
5211:
5210:
5200:
5168:
5162:
5161:
5151:
5119:
5110:
5109:
5099:
5067:
5061:
5060:
5050:
5018:
5009:
5008:
4998:
4966:
4960:
4959:
4949:
4917:
4911:
4910:
4900:
4868:
4862:
4861:
4851:
4841:
4809:
4803:
4802:
4774:
4768:
4767:
4757:
4725:
4719:
4718:
4708:
4676:
4670:
4669:
4633:
4627:
4626:
4616:
4592:
4586:
4585:
4575:
4543:
4530:
4529:
4519:
4495:
4489:
4488:
4478:
4454:
4448:
4447:
4411:
4405:
4404:
4394:
4362:
4356:
4355:
4345:
4313:
4307:
4306:
4296:
4264:
4258:
4257:
4229:
4220:
4219:
4209:
4185:
4179:
4178:
4134:
4128:
4127:
4109:
4085:
4079:
4078:
4068:
4028:
4022:
4021:
4011:
3979:
3973:
3972:
3928:
3922:
3921:
3911:
3887:
3881:
3880:
3870:
3846:
3840:
3839:
3821:
3797:
3791:
3790:
3772:
3755:(7): R248–R250.
3740:
3734:
3733:
3697:
3691:
3690:
3672:
3640:
3631:
3630:
3620:
3596:
3590:
3589:
3571:
3547:
3541:
3540:
3512:
3506:
3505:
3495:
3463:
3457:
3456:
3428:
3422:
3421:
3393:
3387:
3386:
3376:
3367:(7): 1064–1079.
3352:
3346:
3345:
3335:
3312:Clinical Science
3303:
3297:
3296:
3286:
3254:
3248:
3247:
3237:
3227:
3195:
3189:
3188:
3178:
3168:
3144:
3138:
3137:
3127:
3095:
3089:
3088:
3078:
3061:(9): 1016–1023.
3046:
3040:
3039:
3003:
2997:
2996:
2986:
2976:
2952:
2946:
2945:
2935:
2925:
2910:Molecular Cancer
2901:
2892:
2891:
2881:
2849:
2843:
2842:
2832:
2817:Gastroenterology
2808:
2802:
2801:
2791:
2781:
2757:
2751:
2750:
2732:
2700:
2694:
2693:
2675:
2651:
2645:
2644:
2634:
2602:
2596:
2595:
2585:
2553:
2547:
2546:
2536:
2526:
2502:
2496:
2495:
2485:
2453:
2444:
2443:
2407:
2396:
2395:
2385:
2345:
2339:
2338:
2328:
2296:
2290:
2289:
2253:
2247:
2246:
2236:
2196:
2190:
2189:
2179:
2147:
2141:
2140:
2130:
2090:
2084:
2083:
2073:
2041:
2035:
2034:
2024:
1992:
1986:
1985:
1975:
1951:
1945:
1944:
1934:
1902:
1896:
1895:
1885:
1853:
1847:
1846:
1836:
1826:
1802:
1796:
1795:
1751:
1745:
1744:
1726:
1702:
1693:
1692:
1682:
1658:
1652:
1651:
1633:
1609:
1596:
1595:
1585:
1561:
1247:
1246:
1164:Conservation of
1088:(a component of
1056:Lysosomal damage
1011:eukaryotic cells
964:ubiquitin ligase
937:scaffold protein
795:tumor suppressor
647:MAPK/ERK pathway
634:MAPK/ERK pathway
620:insulin receptor
408:oxidative stress
399:
398:
346:, also known as
310:
309:
194:
193:
161:
160:
35:
21:
20:
9054:
9053:
9049:
9048:
9047:
9045:
9044:
9043:
9004:
9003:
9002:
8990:
8982:
8980:
8975:
8887:Oxidoreductases
8873:
8849:Enzyme kinetics
8837:
8833:List of enzymes
8806:
8775:
8746:Catalytic triad
8724:
8719:
8689:
8676:
8624:
8602:
8526:
8509:
8492:
8475:
8446:
8306:
8206:
8177:P70-S6 Kinase 1
8147:
8038:
8000:
7978:
7944:
7920:
7881:
7847:
7553:
7524:
7500:
7481:
7402:
7378:
7339:
7295:
7278:
7254:
7248:Aurora C kinase
7243:Aurora B kinase
7238:Aurora A kinase
7218:
7199:
7165:
7136:
7069:
7035:
6891:
6877:
6863:
6821:
6816:
6763:
6759:
6722:
6718:
6665:
6661:
6608:
6604:
6551:
6547:
6540:
6514:
6510:
6457:
6453:
6424:(8): 991–1012.
6414:
6410:
6371:
6367:
6336:
6332:
6293:
6289:
6244:
6240:
6195:
6188:
6145:
6141:
6110:
6106:
6075:
6071:
6026:
6022:
5975:
5971:
5934:Transplantation
5926:
5922:
5891:(15): e139237.
5877:
5873:
5828:
5824:
5793:
5789:
5744:
5735:
5690:
5686:
5633:
5629:
5592:
5588:
5553:
5549:
5526:(10): 721–726.
5512:
5508:
5485:
5481:
5434:
5430:
5383:
5374:
5329:
5322:
5269:
5265:
5218:
5214:
5169:
5165:
5120:
5113:
5068:
5064:
5019:
5012:
4967:
4963:
4918:
4914:
4889:10.1038/nrc3278
4869:
4865:
4810:
4806:
4775:
4771:
4734:Cell Metabolism
4726:
4722:
4677:
4673:
4634:
4630:
4593:
4589:
4544:
4533:
4496:
4492:
4455:
4451:
4412:
4408:
4363:
4359:
4314:
4310:
4265:
4261:
4230:
4223:
4186:
4182:
4135:
4131:
4086:
4082:
4029:
4025:
3988:Cell Metabolism
3980:
3976:
3929:
3925:
3888:
3884:
3847:
3843:
3798:
3794:
3749:Current Biology
3741:
3737:
3698:
3694:
3641:
3634:
3597:
3593:
3548:
3544:
3513:
3509:
3464:
3460:
3429:
3425:
3394:
3390:
3353:
3349:
3318:(12): 555–573.
3304:
3300:
3255:
3251:
3196:
3192:
3166:10.1186/bcr3128
3145:
3141:
3096:
3092:
3067:10.1038/ncb2329
3047:
3043:
3020:10.1038/nrm2249
3014:(10): 774–785.
3004:
3000:
2953:
2949:
2902:
2895:
2850:
2846:
2809:
2805:
2758:
2754:
2709:Current Biology
2701:
2697:
2652:
2648:
2603:
2599:
2554:
2550:
2503:
2499:
2454:
2447:
2424:10.1038/nrm2672
2408:
2399:
2346:
2342:
2297:
2293:
2254:
2250:
2197:
2193:
2148:
2144:
2091:
2087:
2062:10.1038/nrm3522
2042:
2038:
1993:
1989:
1952:
1948:
1903:
1899:
1854:
1850:
1803:
1799:
1752:
1748:
1703:
1696:
1659:
1655:
1610:
1599:
1562:
1553:
1549:
1509:
1501:clinical trials
1451:
1357:
1329:
1244:
1243:
1236:
1231:
1179:due to lack of
1162:
1106:
1058:
1046:plasma membrane
1004:
976:
906:
854:
838:p70-S6 Kinase 1
826:
803:
764:
759:
740:
719:
698:
661:binds with its
636:
573:
571:Akt/PKB pathway
568:
555:
507:
481:
475:
466:phosphorylation
437:
435:The TSC complex
420:
396:
395:
356:protein complex
38:
17:
16:Protein complex
12:
11:
5:
9052:
9042:
9041:
9039:Human proteins
9036:
9031:
9026:
9021:
9016:
9001:
9000:
8977:
8976:
8974:
8973:
8960:
8947:
8934:
8921:
8908:
8895:
8881:
8879:
8875:
8874:
8872:
8871:
8866:
8861:
8856:
8851:
8845:
8843:
8839:
8838:
8836:
8835:
8830:
8825:
8820:
8814:
8812:
8811:Classification
8808:
8807:
8805:
8804:
8799:
8794:
8789:
8783:
8781:
8777:
8776:
8774:
8773:
8768:
8763:
8758:
8753:
8748:
8743:
8738:
8732:
8730:
8726:
8725:
8718:
8717:
8710:
8703:
8695:
8686:
8685:
8682:
8681:
8678:
8677:
8675:
8674:
8669:
8664:
8659:
8654:
8649:
8644:
8638:
8636:
8626:
8625:
8612:
8611:
8608:
8607:
8604:
8603:
8601:
8600:
8595:
8590:
8585:
8580:
8575:
8570:
8565:
8564:
8563:
8558:
8553:
8548:
8537:
8535:
8534:(EC 2.7.11.30)
8528:
8527:
8525:
8524:
8520:
8518:
8517:(EC 2.7.11.29)
8511:
8510:
8508:
8507:
8503:
8501:
8500:(EC 2.7.11.28)
8494:
8493:
8491:
8490:
8486:
8484:
8483:(EC 2.7.11.27)
8477:
8476:
8474:
8473:
8468:
8463:
8457:
8455:
8454:(EC 2.7.11.26)
8448:
8447:
8445:
8444:
8439:
8434:
8433:
8432:
8427:
8422:
8417:
8412:
8407:
8402:
8392:
8391:
8390:
8385:
8380:
8375:
8365:
8364:
8363:
8358:
8353:
8348:
8343:
8338:
8333:
8328:
8317:
8315:
8314:(EC 2.7.11.25)
8308:
8307:
8305:
8304:
8303:
8302:
8297:
8292:
8282:
8281:
8280:
8275:
8270:
8260:
8259:
8258:
8253:
8248:
8243:
8238:
8233:
8228:
8217:
8215:
8214:(EC 2.7.11.24)
8208:
8207:
8205:
8204:
8199:
8194:
8189:
8184:
8179:
8174:
8169:
8164:
8158:
8156:
8155:(EC 2.7.11.23)
8149:
8148:
8146:
8145:
8140:
8135:
8130:
8125:
8120:
8115:
8110:
8105:
8100:
8095:
8090:
8085:
8080:
8075:
8070:
8065:
8060:
8055:
8049:
8047:
8046:(EC 2.7.11.22)
8040:
8039:
8037:
8036:
8031:
8026:
8021:
8015:
8013:
8012:(EC 2.7.11.21)
8002:
8001:
7988:
7987:
7984:
7983:
7980:
7979:
7977:
7976:
7971:
7966:
7961:
7955:
7953:
7952:(EC 2.7.11.21)
7946:
7945:
7943:
7942:
7937:
7931:
7929:
7928:(EC 2.7.11.20)
7922:
7921:
7919:
7918:
7913:
7908:
7903:
7898:
7892:
7890:
7889:(EC 2.7.11.19)
7883:
7882:
7880:
7879:
7874:
7869:
7864:
7858:
7856:
7855:(EC 2.7.11.18)
7849:
7848:
7846:
7845:
7840:
7835:
7830:
7825:
7820:
7815:
7810:
7805:
7800:
7795:
7790:
7785:
7780:
7775:
7770:
7765:
7760:
7755:
7750:
7745:
7740:
7735:
7730:
7725:
7720:
7715:
7710:
7705:
7700:
7695:
7690:
7685:
7680:
7675:
7670:
7665:
7660:
7655:
7650:
7645:
7640:
7635:
7630:
7625:
7620:
7615:
7610:
7605:
7600:
7595:
7590:
7585:
7580:
7575:
7570:
7564:
7562:
7561:(EC 2.7.11.17)
7555:
7554:
7552:
7551:
7546:
7541:
7535:
7533:
7532:(EC 2.7.11.16)
7526:
7525:
7523:
7522:
7517:
7511:
7509:
7508:(EC 2.7.11.15)
7502:
7501:
7499:
7498:
7492:
7490:
7489:(EC 2.7.11.14)
7483:
7482:
7480:
7479:
7474:
7469:
7464:
7459:
7454:
7449:
7444:
7439:
7434:
7429:
7424:
7419:
7413:
7411:
7410:(EC 2.7.11.13)
7404:
7403:
7401:
7400:
7395:
7389:
7387:
7386:(EC 2.7.11.12)
7380:
7379:
7377:
7376:
7371:
7366:
7361:
7356:
7350:
7348:
7347:(EC 2.7.11.11)
7341:
7340:
7338:
7337:
7332:
7327:
7322:
7317:
7312:
7306:
7304:
7303:(EC 2.7.11.10)
7297:
7296:
7294:
7293:
7289:
7287:
7280:
7279:
7277:
7276:
7271:
7265:
7263:
7256:
7255:
7253:
7252:
7251:
7250:
7245:
7240:
7229:
7227:
7220:
7219:
7217:
7216:
7210:
7208:
7201:
7200:
7198:
7197:
7192:
7187:
7182:
7176:
7174:
7167:
7166:
7164:
7163:
7158:
7153:
7147:
7145:
7138:
7137:
7135:
7134:
7133:
7132:
7127:
7122:
7114:
7113:
7112:
7107:
7099:
7098:
7097:
7092:
7080:
7078:
7071:
7070:
7068:
7067:
7062:
7057:
7052:
7046:
7044:
7037:
7036:
7034:
7033:
7032:
7031:
7021:
7020:
7019:
7014:
7009:
7004:
6994:
6989:
6984:
6983:
6982:
6977:
6972:
6962:
6957:
6952:
6947:
6942:
6937:
6932:
6927:
6922:
6917:
6912:
6906:
6904:
6893:
6892:
6879:
6878:
6862:
6861:
6854:
6847:
6839:
6833:
6832:
6820:
6819:External links
6817:
6815:
6814:
6757:
6716:
6659:
6602:
6545:
6538:
6508:
6451:
6408:
6381:(7): 1109–27.
6365:
6330:
6287:
6258:(4): 766–778.
6238:
6186:
6159:(2): 276–283.
6139:
6104:
6085:(2): 175–183.
6069:
6040:(4): 835–852.
6020:
5969:
5940:(6): 547–561.
5920:
5871:
5822:
5803:(5): 403–412.
5787:
5758:(3): 395–403.
5733:
5704:(2): 265–273.
5684:
5627:
5606:(2): 159–168.
5600:Molecular Cell
5586:
5547:
5506:
5479:
5428:
5372:
5343:(1): 234–243.
5320:
5263:
5212:
5163:
5111:
5062:
5010:
4961:
4912:
4883:(8): 564–571.
4863:
4804:
4769:
4740:(4): 265–277.
4720:
4671:
4628:
4587:
4552:Molecular Cell
4531:
4490:
4449:
4406:
4357:
4308:
4259:
4240:(7): 651–662.
4221:
4200:(4): 683–688.
4180:
4129:
4080:
4023:
3994:(5): 713–724.
3974:
3923:
3882:
3841:
3812:(2): 303–313.
3792:
3735:
3692:
3632:
3591:
3562:(4): 569–580.
3542:
3507:
3478:(5): 851–861.
3458:
3423:
3388:
3347:
3298:
3249:
3190:
3139:
3110:(2): 214–226.
3104:Molecular Cell
3090:
3041:
2998:
2947:
2893:
2864:(2): 761–767.
2844:
2803:
2752:
2695:
2666:(2): 179–193.
2646:
2597:
2548:
2497:
2468:(6): 320–328.
2445:
2418:(5): 307–318.
2397:
2340:
2311:(9): 671–679.
2291:
2270:10.1038/ncb996
2264:(6): 566–571.
2248:
2191:
2162:(9): 524–533.
2142:
2105:(9): 524–533.
2085:
2056:(3): 133–139.
2036:
2007:(2): 121–128.
1987:
1946:
1917:(2): 694–702.
1897:
1862:Molecular Cell
1848:
1797:
1746:
1717:(3): 471–484.
1694:
1673:(4): 895–904.
1667:Molecular Cell
1653:
1624:(2): 163–175.
1597:
1550:
1548:
1545:
1508:
1505:
1450:
1447:
1356:
1353:
1328:
1325:
1295:(mPFC) of the
1235:
1232:
1230:
1227:
1215:immune systems
1207:memory T cells
1203:memory T cells
1199:memory T cells
1161:
1158:
1105:
1102:
1057:
1054:
1019:macroautophagy
1003:
1000:
975:
972:
918:phosphorylates
905:
902:
853:
850:
825:
822:
802:
801:Hypoxic stress
799:
763:
760:
758:
755:
739:
736:
718:
715:
697:
694:
635:
632:
583:. Ultimately,
572:
569:
567:
564:
554:
551:
506:
503:
477:Main article:
474:
471:
436:
433:
419:
416:
339:
338:
335:
334:
329:
325:
324:
319:
315:
314:
306:
305:
295:
289:
288:
284:
283:
278:
272:
271:
269:NM_001163034.1
266:
260:
259:
254:
248:
247:
242:
236:
235:
230:
224:
223:
220:
216:
215:
210:
206:
205:
201:
200:
190:
189:
186:
185:
180:
176:
175:
170:
166:
165:
157:
156:
146:
140:
139:
134:
128:
127:
123:
122:
117:
111:
110:
105:
99:
98:
93:
87:
86:
81:
75:
74:
69:
63:
62:
59:
55:
54:
49:
45:
44:
40:
39:
36:
28:
27:
15:
9:
6:
4:
3:
2:
9051:
9040:
9037:
9035:
9032:
9030:
9027:
9025:
9022:
9020:
9017:
9015:
9012:
9011:
9009:
8999:
8994:
8989:
8988:
8985:
8971:
8967:
8966:
8961:
8958:
8954:
8953:
8948:
8945:
8941:
8940:
8935:
8932:
8928:
8927:
8922:
8919:
8915:
8914:
8909:
8906:
8902:
8901:
8896:
8893:
8889:
8888:
8883:
8882:
8880:
8876:
8870:
8867:
8865:
8862:
8860:
8857:
8855:
8852:
8850:
8847:
8846:
8844:
8840:
8834:
8831:
8829:
8828:Enzyme family
8826:
8824:
8821:
8819:
8816:
8815:
8813:
8809:
8803:
8800:
8798:
8795:
8793:
8792:Cooperativity
8790:
8788:
8785:
8784:
8782:
8778:
8772:
8769:
8767:
8764:
8762:
8759:
8757:
8754:
8752:
8751:Oxyanion hole
8749:
8747:
8744:
8742:
8739:
8737:
8734:
8733:
8731:
8727:
8723:
8716:
8711:
8709:
8704:
8702:
8697:
8696:
8693:
8673:
8670:
8668:
8665:
8663:
8660:
8658:
8655:
8653:
8650:
8648:
8645:
8643:
8640:
8639:
8637:
8635:
8631:
8627:
8622:
8617:
8613:
8599:
8596:
8594:
8591:
8589:
8586:
8584:
8581:
8579:
8576:
8574:
8571:
8569:
8566:
8562:
8559:
8557:
8554:
8552:
8549:
8547:
8544:
8543:
8542:
8539:
8538:
8536:
8533:
8529:
8522:
8521:
8519:
8516:
8512:
8505:
8504:
8502:
8499:
8495:
8488:
8487:
8485:
8482:
8478:
8472:
8469:
8467:
8464:
8462:
8459:
8458:
8456:
8453:
8449:
8443:
8440:
8438:
8435:
8431:
8428:
8426:
8423:
8421:
8418:
8416:
8413:
8411:
8408:
8406:
8403:
8401:
8398:
8397:
8396:
8393:
8389:
8386:
8384:
8381:
8379:
8376:
8374:
8371:
8370:
8369:
8366:
8362:
8359:
8357:
8354:
8352:
8349:
8347:
8344:
8342:
8339:
8337:
8334:
8332:
8329:
8327:
8324:
8323:
8322:
8319:
8318:
8316:
8313:
8309:
8301:
8298:
8296:
8293:
8291:
8288:
8287:
8286:
8283:
8279:
8276:
8274:
8271:
8269:
8266:
8265:
8264:
8261:
8257:
8254:
8252:
8249:
8247:
8244:
8242:
8239:
8237:
8234:
8232:
8229:
8227:
8224:
8223:
8222:
8219:
8218:
8216:
8213:
8209:
8203:
8200:
8198:
8195:
8193:
8190:
8188:
8185:
8183:
8180:
8178:
8175:
8173:
8170:
8168:
8165:
8163:
8160:
8159:
8157:
8154:
8150:
8144:
8141:
8139:
8136:
8134:
8131:
8129:
8126:
8124:
8121:
8119:
8116:
8114:
8111:
8109:
8106:
8104:
8101:
8099:
8096:
8094:
8091:
8089:
8086:
8084:
8081:
8079:
8076:
8074:
8071:
8069:
8066:
8064:
8061:
8059:
8056:
8054:
8051:
8050:
8048:
8045:
8041:
8035:
8032:
8030:
8027:
8025:
8022:
8020:
8017:
8016:
8014:
8011:
8007:
8003:
7998:
7993:
7989:
7975:
7972:
7970:
7967:
7965:
7962:
7960:
7957:
7956:
7954:
7951:
7947:
7941:
7938:
7936:
7933:
7932:
7930:
7927:
7923:
7917:
7914:
7912:
7909:
7907:
7904:
7902:
7899:
7897:
7894:
7893:
7891:
7888:
7884:
7878:
7875:
7873:
7870:
7868:
7865:
7863:
7860:
7859:
7857:
7854:
7850:
7844:
7841:
7839:
7836:
7834:
7831:
7829:
7826:
7824:
7821:
7819:
7816:
7814:
7811:
7809:
7806:
7804:
7801:
7799:
7796:
7794:
7791:
7789:
7786:
7784:
7781:
7779:
7776:
7774:
7771:
7769:
7766:
7764:
7761:
7759:
7756:
7754:
7751:
7749:
7746:
7744:
7741:
7739:
7736:
7734:
7731:
7729:
7726:
7724:
7721:
7719:
7716:
7714:
7711:
7709:
7706:
7704:
7701:
7699:
7696:
7694:
7691:
7689:
7686:
7684:
7681:
7679:
7676:
7674:
7671:
7669:
7666:
7664:
7661:
7659:
7656:
7654:
7651:
7649:
7646:
7644:
7641:
7639:
7636:
7634:
7631:
7629:
7626:
7624:
7621:
7619:
7616:
7614:
7611:
7609:
7606:
7604:
7601:
7599:
7596:
7594:
7591:
7589:
7586:
7584:
7581:
7579:
7576:
7574:
7571:
7569:
7566:
7565:
7563:
7560:
7556:
7550:
7547:
7545:
7542:
7540:
7537:
7536:
7534:
7531:
7527:
7521:
7518:
7516:
7513:
7512:
7510:
7507:
7503:
7497:
7494:
7493:
7491:
7488:
7484:
7478:
7475:
7473:
7470:
7468:
7465:
7463:
7460:
7458:
7455:
7453:
7450:
7448:
7445:
7443:
7440:
7438:
7435:
7433:
7430:
7428:
7425:
7423:
7420:
7418:
7415:
7414:
7412:
7409:
7405:
7399:
7396:
7394:
7391:
7390:
7388:
7385:
7381:
7375:
7372:
7370:
7367:
7365:
7362:
7360:
7357:
7355:
7352:
7351:
7349:
7346:
7342:
7336:
7333:
7331:
7328:
7326:
7323:
7321:
7318:
7316:
7313:
7311:
7308:
7307:
7305:
7302:
7298:
7291:
7290:
7288:
7286:(EC 2.7.11.9)
7285:
7281:
7275:
7272:
7270:
7267:
7266:
7264:
7262:(EC 2.7.11.8)
7261:
7257:
7249:
7246:
7244:
7241:
7239:
7236:
7235:
7234:
7233:Aurora kinase
7231:
7230:
7228:
7226:(EC 2.7.11.7)
7225:
7221:
7215:
7212:
7211:
7209:
7207:(EC 2.7.11.6)
7206:
7202:
7196:
7193:
7191:
7188:
7186:
7183:
7181:
7178:
7177:
7175:
7173:(EC 2.7.11.5)
7172:
7168:
7162:
7159:
7157:
7154:
7152:
7149:
7148:
7146:
7144:(EC 2.7.11.4)
7143:
7139:
7131:
7128:
7126:
7123:
7121:
7118:
7117:
7115:
7111:
7108:
7106:
7103:
7102:
7100:
7096:
7093:
7091:
7088:
7087:
7085:
7082:
7081:
7079:
7077:(EC 2.7.11.3)
7076:
7072:
7066:
7063:
7061:
7058:
7056:
7053:
7051:
7048:
7047:
7045:
7043:(EC 2.7.11.2)
7042:
7038:
7030:
7027:
7026:
7025:
7022:
7018:
7015:
7013:
7010:
7008:
7005:
7003:
7000:
6999:
6998:
6997:EIF-2 kinases
6995:
6993:
6990:
6988:
6985:
6981:
6978:
6976:
6973:
6971:
6968:
6967:
6966:
6963:
6961:
6958:
6956:
6953:
6951:
6948:
6946:
6943:
6941:
6938:
6936:
6933:
6931:
6928:
6926:
6923:
6921:
6918:
6916:
6913:
6911:
6908:
6907:
6905:
6903:(EC 2.7.11.1)
6902:
6898:
6894:
6889:
6884:
6880:
6875:
6871:
6867:
6860:
6855:
6853:
6848:
6846:
6841:
6840:
6837:
6830:
6826:
6823:
6822:
6810:
6806:
6801:
6796:
6792:
6788:
6784:
6780:
6776:
6772:
6768:
6761:
6753:
6749:
6744:
6739:
6735:
6731:
6727:
6720:
6712:
6708:
6703:
6698:
6694:
6690:
6686:
6682:
6678:
6674:
6670:
6663:
6655:
6651:
6646:
6641:
6637:
6633:
6629:
6625:
6621:
6617:
6613:
6606:
6598:
6594:
6589:
6584:
6580:
6576:
6572:
6568:
6564:
6560:
6556:
6549:
6541:
6535:
6531:
6527:
6523:
6519:
6512:
6504:
6500:
6495:
6490:
6486:
6482:
6478:
6474:
6470:
6466:
6462:
6455:
6447:
6443:
6439:
6435:
6431:
6427:
6423:
6419:
6412:
6404:
6400:
6396:
6392:
6388:
6384:
6380:
6376:
6369:
6361:
6357:
6353:
6349:
6345:
6341:
6334:
6326:
6322:
6318:
6314:
6310:
6306:
6302:
6298:
6291:
6283:
6279:
6274:
6269:
6265:
6261:
6257:
6253:
6249:
6242:
6234:
6230:
6225:
6220:
6216:
6212:
6208:
6204:
6200:
6193:
6191:
6182:
6178:
6174:
6170:
6166:
6162:
6158:
6154:
6150:
6143:
6135:
6131:
6127:
6123:
6119:
6115:
6108:
6100:
6096:
6092:
6088:
6084:
6080:
6073:
6065:
6061:
6056:
6051:
6047:
6043:
6039:
6035:
6031:
6024:
6016:
6012:
6007:
6002:
5997:
5992:
5988:
5984:
5980:
5973:
5965:
5961:
5957:
5953:
5948:
5943:
5939:
5935:
5931:
5924:
5916:
5912:
5907:
5902:
5898:
5894:
5890:
5886:
5882:
5875:
5867:
5863:
5858:
5853:
5849:
5845:
5841:
5837:
5833:
5826:
5818:
5814:
5810:
5806:
5802:
5798:
5791:
5783:
5779:
5774:
5769:
5765:
5761:
5757:
5753:
5749:
5742:
5740:
5738:
5729:
5725:
5720:
5715:
5711:
5707:
5703:
5699:
5695:
5688:
5680:
5676:
5671:
5666:
5662:
5658:
5654:
5650:
5646:
5642:
5638:
5631:
5623:
5619:
5614:
5609:
5605:
5601:
5597:
5590:
5582:
5578:
5574:
5570:
5566:
5562:
5558:
5551:
5543:
5539:
5534:
5529:
5525:
5521:
5517:
5510:
5502:
5498:
5494:
5490:
5483:
5475:
5471:
5466:
5461:
5456:
5451:
5447:
5443:
5439:
5432:
5424:
5420:
5415:
5410:
5405:
5400:
5396:
5392:
5391:F1000Research
5388:
5381:
5379:
5377:
5368:
5364:
5359:
5354:
5350:
5346:
5342:
5338:
5334:
5327:
5325:
5316:
5312:
5307:
5302:
5298:
5294:
5290:
5286:
5282:
5278:
5274:
5267:
5259:
5255:
5250:
5245:
5240:
5235:
5231:
5227:
5223:
5216:
5208:
5204:
5199:
5194:
5190:
5186:
5182:
5178:
5174:
5167:
5159:
5155:
5150:
5145:
5141:
5137:
5133:
5129:
5125:
5118:
5116:
5107:
5103:
5098:
5093:
5089:
5085:
5081:
5077:
5073:
5066:
5058:
5054:
5049:
5044:
5040:
5036:
5032:
5028:
5024:
5017:
5015:
5006:
5002:
4997:
4992:
4988:
4984:
4980:
4976:
4972:
4965:
4957:
4953:
4948:
4943:
4939:
4935:
4931:
4927:
4923:
4916:
4908:
4904:
4899:
4894:
4890:
4886:
4882:
4878:
4874:
4867:
4859:
4855:
4850:
4845:
4840:
4835:
4831:
4827:
4823:
4819:
4815:
4808:
4800:
4796:
4792:
4788:
4784:
4780:
4773:
4765:
4761:
4756:
4751:
4747:
4743:
4739:
4735:
4731:
4724:
4716:
4712:
4707:
4702:
4698:
4694:
4690:
4686:
4682:
4675:
4667:
4663:
4659:
4655:
4651:
4647:
4643:
4639:
4632:
4624:
4620:
4615:
4610:
4606:
4602:
4598:
4591:
4583:
4579:
4574:
4569:
4565:
4561:
4557:
4553:
4549:
4542:
4540:
4538:
4536:
4527:
4523:
4518:
4513:
4509:
4505:
4501:
4494:
4486:
4482:
4477:
4472:
4468:
4464:
4460:
4453:
4445:
4441:
4437:
4433:
4429:
4425:
4421:
4417:
4410:
4402:
4398:
4393:
4388:
4384:
4380:
4376:
4372:
4368:
4361:
4353:
4349:
4344:
4339:
4335:
4331:
4327:
4323:
4319:
4312:
4304:
4300:
4295:
4290:
4286:
4282:
4278:
4274:
4270:
4263:
4255:
4251:
4247:
4243:
4239:
4235:
4228:
4226:
4217:
4213:
4208:
4203:
4199:
4195:
4191:
4184:
4176:
4172:
4168:
4164:
4160:
4156:
4152:
4148:
4144:
4140:
4133:
4125:
4121:
4117:
4113:
4108:
4103:
4100:(8): 109564.
4099:
4095:
4091:
4084:
4076:
4072:
4067:
4062:
4058:
4054:
4050:
4046:
4042:
4038:
4034:
4027:
4019:
4015:
4010:
4005:
4001:
3997:
3993:
3989:
3985:
3978:
3970:
3966:
3962:
3958:
3954:
3950:
3946:
3942:
3938:
3934:
3927:
3919:
3915:
3910:
3905:
3901:
3897:
3893:
3886:
3878:
3874:
3869:
3864:
3860:
3856:
3852:
3845:
3837:
3833:
3829:
3825:
3820:
3815:
3811:
3807:
3803:
3796:
3788:
3784:
3780:
3776:
3771:
3766:
3762:
3758:
3754:
3750:
3746:
3739:
3731:
3727:
3723:
3719:
3715:
3711:
3707:
3703:
3696:
3688:
3684:
3680:
3676:
3671:
3666:
3662:
3658:
3654:
3650:
3646:
3639:
3637:
3628:
3624:
3619:
3614:
3610:
3606:
3602:
3595:
3587:
3583:
3579:
3575:
3570:
3565:
3561:
3557:
3553:
3546:
3538:
3534:
3530:
3526:
3522:
3518:
3511:
3503:
3499:
3494:
3489:
3485:
3481:
3477:
3473:
3469:
3462:
3454:
3450:
3446:
3442:
3438:
3434:
3427:
3419:
3415:
3411:
3407:
3403:
3399:
3392:
3384:
3380:
3375:
3370:
3366:
3362:
3358:
3351:
3343:
3339:
3334:
3329:
3325:
3321:
3317:
3313:
3309:
3302:
3294:
3290:
3285:
3280:
3276:
3272:
3268:
3264:
3260:
3253:
3245:
3241:
3236:
3231:
3226:
3221:
3217:
3213:
3209:
3205:
3201:
3194:
3186:
3182:
3177:
3172:
3167:
3162:
3158:
3154:
3150:
3143:
3135:
3131:
3126:
3121:
3117:
3113:
3109:
3105:
3101:
3094:
3086:
3082:
3077:
3072:
3068:
3064:
3060:
3056:
3052:
3045:
3037:
3033:
3029:
3025:
3021:
3017:
3013:
3009:
3002:
2994:
2990:
2985:
2980:
2975:
2970:
2966:
2962:
2958:
2951:
2943:
2939:
2934:
2929:
2924:
2919:
2915:
2911:
2907:
2900:
2898:
2889:
2885:
2880:
2875:
2871:
2867:
2863:
2859:
2855:
2848:
2840:
2836:
2831:
2826:
2822:
2818:
2814:
2807:
2799:
2795:
2790:
2785:
2780:
2775:
2771:
2767:
2763:
2756:
2748:
2744:
2740:
2736:
2731:
2726:
2722:
2718:
2714:
2710:
2706:
2699:
2691:
2687:
2683:
2679:
2674:
2669:
2665:
2661:
2657:
2650:
2642:
2638:
2633:
2628:
2624:
2620:
2616:
2612:
2608:
2601:
2593:
2589:
2584:
2579:
2575:
2571:
2567:
2563:
2559:
2552:
2544:
2540:
2535:
2530:
2525:
2520:
2516:
2512:
2508:
2501:
2493:
2489:
2484:
2479:
2475:
2471:
2467:
2463:
2459:
2452:
2450:
2441:
2437:
2433:
2429:
2425:
2421:
2417:
2413:
2406:
2404:
2402:
2393:
2389:
2384:
2379:
2375:
2371:
2367:
2363:
2359:
2355:
2351:
2344:
2336:
2332:
2327:
2322:
2318:
2314:
2310:
2306:
2302:
2295:
2287:
2283:
2279:
2275:
2271:
2267:
2263:
2259:
2252:
2244:
2240:
2235:
2230:
2226:
2222:
2218:
2214:
2210:
2206:
2202:
2195:
2187:
2183:
2178:
2173:
2169:
2165:
2161:
2157:
2153:
2146:
2138:
2134:
2129:
2124:
2120:
2119:1721.1/106904
2116:
2112:
2108:
2104:
2100:
2096:
2089:
2081:
2077:
2072:
2067:
2063:
2059:
2055:
2051:
2047:
2040:
2032:
2028:
2023:
2018:
2014:
2010:
2006:
2002:
1998:
1991:
1983:
1979:
1974:
1969:
1965:
1961:
1957:
1950:
1942:
1938:
1933:
1928:
1924:
1920:
1916:
1912:
1908:
1901:
1893:
1889:
1884:
1879:
1875:
1871:
1867:
1863:
1859:
1852:
1844:
1840:
1835:
1830:
1825:
1820:
1816:
1812:
1808:
1801:
1793:
1789:
1785:
1781:
1777:
1773:
1769:
1765:
1761:
1757:
1750:
1742:
1738:
1734:
1730:
1725:
1720:
1716:
1712:
1708:
1701:
1699:
1690:
1686:
1681:
1676:
1672:
1668:
1664:
1657:
1649:
1645:
1641:
1637:
1632:
1627:
1623:
1619:
1615:
1608:
1606:
1604:
1602:
1593:
1589:
1584:
1579:
1575:
1571:
1567:
1560:
1558:
1556:
1551:
1544:
1541:
1539:
1535:
1531:
1527:
1523:
1519:
1515:
1504:
1502:
1498:
1494:
1490:
1485:
1483:
1479:
1475:
1471:
1466:
1461:
1457:
1446:
1444:
1440:
1436:
1432:
1428:
1427:heart attacks
1424:
1420:
1416:
1412:
1408:
1404:
1402:
1398:
1394:
1390:
1386:
1382:
1377:
1376:water soluble
1372:
1370:
1365:
1361:
1352:
1350:
1346:
1342:
1338:
1334:
1324:
1322:
1318:
1314:
1310:
1306:
1302:
1298:
1294:
1290:
1287:
1282:
1280:
1276:
1272:
1268:
1264:
1261:
1257:
1253:
1249:
1240:
1226:
1224:
1220:
1216:
1212:
1208:
1204:
1200:
1196:
1191:
1189:
1184:
1182:
1178:
1175:
1171:
1167:
1157:
1154:
1152:
1151:electrophilic
1148:
1144:
1139:
1137:
1133:
1129:
1125:
1121:
1116:
1114:
1110:
1101:
1099:
1095:
1091:
1087:
1083:
1079:
1075:
1071:
1067:
1063:
1053:
1049:
1047:
1043:
1039:
1035:
1030:
1028:
1024:
1020:
1016:
1012:
1008:
999:
997:
992:
987:
985:
981:
980:S. cerevisiae
971:
969:
965:
961:
956:
952:
950:
946:
942:
938:
933:
931:
927:
923:
919:
914:
912:
901:
899:
895:
891:
887:
883:
879:
875:
871:
867:
863:
859:
849:
847:
843:
839:
830:
821:
818:
816:
812:
808:
798:
796:
793:, is a known
792:
787:
783:
779:
777:
773:
769:
762:Energy status
754:
752:
748:
744:
735:
733:
729:
724:
714:
711:
707:
703:
693:
691:
687:
682:
680:
676:
672:
668:
664:
660:
656:
652:
651:G protein Ras
648:
644:
640:
631:
629:
625:
621:
617:
613:
609:
604:
602:
598:
593:
590:
586:
582:
578:
559:
550:
548:
544:
540:
536:
532:
528:
524:
520:
516:
512:
502:
499:
495:
491:
486:
480:
470:
467:
463:
458:
454:
450:
446:
442:
429:
424:
415:
411:
409:
405:
401:
392:
388:
384:
380:
376:
372:
368:
364:
359:
357:
353:
349:
345:
333:
330:
326:
323:
320:
316:
311:
307:
304:
303:
299:
296:
294:
290:
285:
282:
279:
277:
273:
270:
267:
265:
261:
258:
255:
253:
249:
246:
243:
241:
237:
234:
231:
229:
225:
221:
217:
214:
211:
207:
202:
199:
195:
184:
181:
177:
174:
171:
167:
162:
158:
155:
154:
150:
147:
145:
141:
138:
135:
133:
129:
124:
121:
118:
116:
112:
109:
106:
104:
100:
97:
94:
92:
88:
85:
82:
80:
76:
73:
70:
68:
64:
60:
56:
53:
50:
46:
41:
34:
29:
26:
22:
19:
8965:Translocases
8962:
8949:
8936:
8923:
8910:
8900:Transferases
8897:
8884:
8741:Binding site
8172:P70S6 kinase
6774:
6770:
6760:
6733:
6729:
6719:
6676:
6672:
6662:
6619:
6615:
6605:
6562:
6558:
6548:
6521:
6511:
6468:
6464:
6454:
6421:
6417:
6411:
6378:
6374:
6368:
6343:
6339:
6333:
6300:
6296:
6290:
6255:
6251:
6241:
6206:
6202:
6156:
6152:
6142:
6117:
6113:
6107:
6082:
6078:
6072:
6037:
6033:
6023:
5986:
5982:
5972:
5937:
5933:
5923:
5888:
5884:
5874:
5842:(1): 28–38.
5839:
5835:
5825:
5800:
5796:
5790:
5755:
5751:
5701:
5697:
5687:
5644:
5640:
5630:
5603:
5599:
5589:
5564:
5560:
5550:
5523:
5519:
5509:
5492:
5488:
5482:
5445:
5441:
5431:
5394:
5390:
5340:
5336:
5280:
5276:
5266:
5229:
5225:
5215:
5180:
5176:
5166:
5134:(98): ra75.
5131:
5127:
5079:
5075:
5065:
5030:
5026:
4978:
4975:EMBO Reports
4974:
4964:
4929:
4926:Nitric Oxide
4925:
4915:
4880:
4876:
4866:
4821:
4817:
4807:
4782:
4778:
4772:
4737:
4733:
4723:
4688:
4684:
4674:
4641:
4637:
4631:
4604:
4600:
4590:
4555:
4551:
4507:
4503:
4493:
4466:
4462:
4452:
4419:
4415:
4409:
4377:(2): 73–80.
4374:
4370:
4360:
4325:
4321:
4311:
4276:
4272:
4262:
4237:
4233:
4197:
4193:
4183:
4142:
4138:
4132:
4097:
4094:Cell Reports
4093:
4083:
4040:
4036:
4026:
3991:
3987:
3977:
3936:
3932:
3926:
3899:
3895:
3885:
3858:
3854:
3844:
3809:
3805:
3795:
3752:
3748:
3738:
3705:
3701:
3695:
3655:(1): 78–82.
3652:
3649:FEBS Letters
3648:
3608:
3604:
3594:
3559:
3555:
3545:
3523:(1): 19–31.
3520:
3516:
3510:
3475:
3471:
3461:
3439:(1): 43–57.
3436:
3432:
3426:
3404:(1): 17–24.
3401:
3397:
3391:
3364:
3360:
3350:
3315:
3311:
3301:
3266:
3262:
3252:
3207:
3203:
3193:
3156:
3152:
3142:
3107:
3103:
3093:
3058:
3054:
3044:
3011:
3007:
3001:
2964:
2960:
2950:
2913:
2909:
2861:
2857:
2847:
2820:
2816:
2806:
2769:
2765:
2755:
2712:
2708:
2698:
2663:
2659:
2649:
2614:
2610:
2600:
2568:(1): 14–24.
2565:
2561:
2551:
2514:
2510:
2500:
2465:
2461:
2415:
2411:
2357:
2353:
2343:
2308:
2304:
2294:
2261:
2257:
2251:
2208:
2204:
2194:
2159:
2155:
2145:
2102:
2098:
2088:
2053:
2049:
2039:
2004:
2001:EMBO Reports
2000:
1990:
1963:
1959:
1949:
1914:
1910:
1900:
1865:
1861:
1851:
1814:
1810:
1800:
1759:
1755:
1749:
1714:
1710:
1670:
1666:
1656:
1621:
1617:
1573:
1569:
1542:
1510:
1486:
1452:
1405:
1385:temsirolimus
1373:
1358:
1330:
1283:
1260:myofibrillar
1237:
1192:
1185:
1163:
1155:
1146:
1140:
1117:
1113:mitochondria
1107:
1059:
1050:
1031:
1005:
988:
983:
979:
977:
957:
953:
934:
915:
907:
898:hairpin loop
855:
835:
819:
804:
788:
784:
780:
765:
741:
720:
699:
683:
637:
605:
594:
574:
508:
489:
482:
438:
412:
360:
351:
347:
343:
342:
300:
219:Alt. symbols
151:
58:Alt. symbols
18:
8736:Active site
8623:(EC 2.7.12)
8010:Polo kinase
7950:Polo kinase
6565:(1): 3194.
5989:: 393–404.
5885:JCI Insight
5177:Development
4691:(1): 1–13.
4644:: 373–399.
4607:: 128–132.
4328:(1): 2–11.
4279:: 105–137.
1474:gedatolisib
1337:resveratrol
1181:trophoblast
966:Beta-TrCP (
894:start codon
840:(S6K1) and
723:Wnt pathway
717:Wnt pathway
696:JNK pathway
663:SH2 domains
462:heterodimer
391:amino acids
322:Swiss-model
204:Identifiers
173:Swiss-model
43:Identifiers
9008:Categories
8939:Isomerases
8913:Hydrolases
8780:Regulation
7301:IκB kinase
6876:2.7.11-12)
6679:(1): 548.
6303:: 113975.
5836:Aging Cell
5698:Aging Cell
4194:Cell Cycle
3159:(1): R35.
2967:: 849541.
2611:Oncotarget
1547:References
1381:everolimus
1327:Inhibitors
1321:depression
1234:Activators
1166:stem cells
1160:Stem cells
1132:glycolysis
1070:Galectin-8
1066:galectin-8
1015:organelles
984:C. elegans
608:beta cells
490:Rag GTPase
389:, certain
318:Structures
313:Search for
287:Other data
222:KOG1, Mip1
169:Structures
164:Search for
126:Other data
9029:EC 2.7.11
8818:EC number
7427:PKC alpha
6403:207474033
6325:215803320
4932:: 45–53.
4124:237306510
1522:HY-124798
1407:Sirolimus
1389:rapamycin
1360:Rapamycin
1313:modulator
1303:effects.
1177:lethality
1174:embryonic
1098:autophagy
1062:lysosomes
1023:cytoplasm
1007:Autophagy
1002:Autophagy
922:threonine
743:Cytokines
738:Cytokines
498:lysosomes
494:endosomes
383:rapamycin
228:NCBI gene
132:EC number
108:NM_004958
67:NCBI gene
8842:Kinetics
8766:Cofactor
8729:Activity
7783:KIAA0999
7678:MAPKAPK5
7673:MAPKAPK3
7668:MAPKAPK2
6809:23325216
6752:31231029
6711:29416044
6654:29236692
6597:31324799
6503:22461615
6446:22677288
6438:23668243
6395:21591993
6360:21651476
6317:32298692
6282:20203102
6233:21333749
6181:18525093
6173:22130643
6134:22475451
6099:22687453
6064:21763970
6015:22910420
5964:24753934
5956:22941182
5915:32759497
5866:26463117
5817:23352077
5782:21216931
5728:25652038
5679:22461615
5622:16603397
5581:17275731
5501:22993301
5474:20851890
5423:29899972
5367:20536567
5315:19543266
5258:22888331
5207:21791526
5158:19934433
5106:15485918
5057:15254238
5005:15995659
4956:26989010
4907:22810811
4858:21325052
4799:16115017
4764:17403371
4715:19061483
4666:17229119
4658:15377225
4623:25542097
4582:29625033
4526:16247498
4485:10806201
4444:13379878
4436:17956308
4401:22257882
4352:22025673
4303:23072311
4254:23406030
4216:20139716
4175:42188272
4167:16293764
4116:34433065
4075:19587680
4018:22560223
3969:44756177
3961:11292860
3918:15905173
3877:15899889
3836:13437701
3828:18423201
3687:36947968
3627:11914378
3586:11118504
3578:16286006
3537:22168162
3502:16540693
3453:10216943
3418:21906675
3383:21436840
3361:Leukemia
3342:22390198
3293:15545625
3244:20176937
3185:22353783
3134:18439900
3085:21892142
3036:38533515
3028:17712357
2993:22899934
2942:22325146
2888:24333448
2839:21320501
2798:22493283
2747:15088729
2739:18722121
2690:18663447
2682:15851026
2641:23085539
2592:23471659
2543:17517883
2492:21531565
2440:30790160
2432:19339977
2392:23723238
2335:21785113
2286:25954873
2278:12766776
2243:18497260
2186:22749019
2137:22749019
2080:23361334
2031:22240970
1982:23246968
1960:Oncogene
1941:20071534
1892:35772404
1843:26937223
1792:44444716
1784:11729323
1741:17195001
1733:16469695
1689:12718876
1640:12150925
1592:15314020
1497:phase II
1364:scaffold
1345:caffeine
1341:curcumin
1317:sestrin2
1289:ketamine
1248:-leucine
1217:. This
996:lysosome
930:ribosome
874:helicase
655:farnesyl
639:Mitogens
428:lysosome
400:-leucine
332:InterPro
183:InterPro
137:2.7.11.1
8998:Biology
8952:Ligases
8722:Enzymes
8442:MAP3K14
8420:MAP3K11
8415:MAP3K10
8405:MAP3K13
8400:MAP3K12
8202:RPS6KC1
8197:RPS6KA1
8192:RPS6KA3
8187:RPS6KA2
8182:RPS6KB2
8167:RPS6KA4
8162:RPS6KA5
7813:Kalirin
7778:SNF1LK2
7017:EIF2AK4
7012:EIF2AK3
6866:Kinases
6800:3687363
6779:Bibcode
6702:5803267
6681:Bibcode
6645:5750076
6624:Bibcode
6588:6642166
6567:Bibcode
6494:3324089
6473:Bibcode
6465:Science
6273:5417537
6224:3073023
6055:3587783
6006:3402052
5906:7455083
5857:4717280
5773:3413411
5719:4364838
5670:3324089
5649:Bibcode
5641:Science
5542:1102508
5465:2978567
5414:5968361
5397:: 659.
5358:3760155
5306:2710807
5285:Bibcode
5249:3412259
5232:: 228.
5198:3143559
5149:4020596
4996:1369281
4947:4860108
4898:3836441
4849:3054028
4826:Bibcode
4755:3460550
4706:2605959
4601:Methods
4573:5911935
4392:3296815
4343:3255710
4294:3971121
4147:Bibcode
4139:Science
4066:2786175
4045:Bibcode
4009:3348514
3941:Bibcode
3933:Science
3787:2528173
3779:9545190
3757:Bibcode
3730:9445476
3710:Bibcode
3702:Science
3679:9247127
3657:Bibcode
3493:1440912
3333:3367961
3235:2842042
3212:Bibcode
3176:3496153
3125:2674027
3076:3249400
2984:3412117
2933:3293036
2789:3365776
2717:Bibcode
2632:3717945
2583:3936017
2534:3199301
2483:3112285
2383:3728654
2362:Bibcode
2354:Science
2326:3160786
2234:2475333
2213:Bibcode
2205:Science
2177:3432651
2128:3432651
2071:3988467
2022:3271343
1932:3665010
1883:9444906
1834:4774173
1764:Bibcode
1756:Science
1648:4656930
1538:NV-6297
1534:NV-5440
1478:WYE-687
1349:alcohol
1305:NV-5138
1219:paradox
1211:B cells
1086:LAMTOR1
1074:SLC38A9
916:mTORC1
807:hypoxic
612:glucose
354:, is a
328:Domains
298:Chr. 17
276:UniProt
179:Domains
115:UniProt
8984:Portal
8926:Lyases
8672:MAP2K7
8667:MAP2K6
8662:MAP2K5
8657:MAP2K4
8652:MAP2K3
8647:MAP2K2
8642:MAP2K1
8593:ACVRL1
8588:ACVR2B
8583:ACVR2A
8578:ACVR1C
8573:ACVR1B
8556:BMPR1B
8551:BMPR1A
8425:MAP3K7
8410:MAP3K9
8361:MAP3K8
8356:MAP3K7
8351:MAP3K6
8346:MAP3K5
8341:MAP3K4
8336:MAP3K3
8331:MAP3K2
8326:MAP3K1
8300:MAPK14
8295:MAPK13
8290:MAPK11
8278:MAPK10
8256:MAPK15
8251:MAPK12
8143:CDC2L1
8118:CDC2L5
7793:SNF1LK
7618:CAMK2G
7613:CAMK2D
7608:CAMK2B
7603:CAMK2A
7593:CAMK1G
7588:CAMK1D
7583:CAMK1B
7578:CAMK1A
7432:PRKCB1
7369:PRKACA
7364:PRKACB
7359:PRKACG
7335:IKBKAP
7161:BCKDHB
7156:BCKDHA
7130:PRKAG3
7125:PRKAG2
7120:PRKAG1
7110:PRKAB2
7105:PRKAB1
7095:PRKAA2
7090:PRKAA1
6935:STK38L
6831:(MeSH)
6807:
6797:
6771:Nature
6750:
6709:
6699:
6652:
6642:
6616:Nature
6595:
6585:
6536:
6501:
6491:
6444:
6436:
6401:
6393:
6358:
6323:
6315:
6280:
6270:
6231:
6221:
6179:
6171:
6132:
6097:
6062:
6052:
6013:
6003:
5962:
5954:
5913:
5903:
5864:
5854:
5815:
5780:
5770:
5726:
5716:
5677:
5667:
5620:
5579:
5557:Liu LF
5540:
5499:
5472:
5462:
5421:
5411:
5365:
5355:
5313:
5303:
5277:Nature
5256:
5246:
5205:
5195:
5156:
5146:
5104:
5097:522282
5094:
5055:
5048:444840
5045:
5003:
4993:
4954:
4944:
4905:
4895:
4856:
4846:
4797:
4762:
4752:
4713:
4703:
4664:
4656:
4621:
4580:
4570:
4524:
4483:
4442:
4434:
4399:
4389:
4350:
4340:
4301:
4291:
4252:
4214:
4173:
4165:
4122:
4114:
4073:
4063:
4037:Nature
4016:
4006:
3967:
3959:
3916:
3875:
3834:
3826:
3785:
3777:
3728:
3685:
3677:
3625:
3584:
3576:
3535:
3500:
3490:
3451:
3416:
3381:
3340:
3330:
3291:
3284:534650
3281:
3242:
3232:
3183:
3173:
3132:
3122:
3083:
3073:
3034:
3026:
2991:
2981:
2940:
2930:
2886:
2837:
2796:
2786:
2745:
2737:
2688:
2680:
2639:
2629:
2590:
2580:
2541:
2531:
2490:
2480:
2438:
2430:
2390:
2380:
2333:
2323:
2284:
2276:
2241:
2231:
2184:
2174:
2135:
2125:
2078:
2068:
2029:
2019:
1980:
1939:
1929:
1890:
1880:
1841:
1831:
1790:
1782:
1739:
1731:
1687:
1646:
1638:
1590:
1518:PRAS40
1482:XL-388
1470:FKBP12
1465:mTORC2
1393:mTORC2
1369:mTORC2
1347:, and
1309:ligand
1273:, and
1267:myosin
1250:, and
1143:NFE2L2
1084:, and
949:intron
858:4E-BP1
852:4E-BP1
844:, the
842:4E-BP1
710:Raptor
690:PRAS40
686:raptor
597:4E-BP1
589:14-3-3
579:(RTK)-
547:DEPDC5
511:DEPDC5
445:GTPase
379:DEPTOR
375:PRAS40
344:mTORC1
281:Q8N122
264:RefSeq
257:607130
209:Symbol
149:Chr. 1
120:P42345
103:RefSeq
96:601231
48:Symbol
8878:Types
8634:MAP2K
8568:ACVR1
8561:BMPR2
8546:BMPR1
8471:GSK-3
8312:MAP3K
8273:MAPK9
8268:MAPK8
8246:MAPK7
8241:MAPK6
8236:MAPK4
8231:MAPK3
8226:MAPK1
8138:PFTK1
8133:PCTK3
8128:PCTK2
8123:PCTK1
8113:CDK12
8108:CDK10
8083:CDKL5
8063:CDKL2
7940:STK19
7935:EEF2K
7916:PHKG2
7911:PHKG1
7901:PHKA2
7896:PHKA1
7877:MYLK4
7872:MYLK3
7867:MYLK2
7843:DCLK1
7838:Titin
7828:TRIB3
7823:TRIB2
7818:TRIB1
7808:TSSK2
7788:STK40
7773:PSKH1
7768:PRKD3
7763:PRKD2
7743:PHKG2
7738:PHKG1
7728:OBSCN
7723:NUAK2
7718:NUAK1
7713:MKNK2
7708:MKNK1
7698:MARK4
7693:MARK3
7688:MARK2
7683:MARK1
7663:STK11
7658:DAPK3
7653:DAPK2
7648:DAPK1
7643:CHEK2
7638:CHEK1
7623:CAMK4
7598:CAMK2
7573:CAMK1
7568:BRSK2
7462:PRKCQ
7457:PRKCI
7452:PRKCG
7447:PRKCH
7442:PRKCE
7437:PRKCD
7398:PRKG1
7330:IKBKG
7325:IKBKE
7274:STK10
7269:FASTK
7195:IDH3G
7190:IDH3B
7185:IDH3A
7151:BCKDK
6945:ROCK1
6930:STK38
6925:MAST2
6920:MAST1
6915:LATS2
6910:LATS1
6442:S2CID
6399:S2CID
6321:S2CID
6177:S2CID
5960:S2CID
4662:S2CID
4440:S2CID
4171:S2CID
4120:S2CID
3965:S2CID
3832:S2CID
3783:S2CID
3683:S2CID
3582:S2CID
3032:S2CID
2916:: 7.
2743:S2CID
2686:S2CID
2436:S2CID
2282:S2CID
1817:: 8.
1788:S2CID
1737:S2CID
1644:S2CID
1514:DL001
1423:stent
1307:is a
1297:brain
1275:actin
1271:titin
1170:aging
1082:RRAGB
1078:RRAGA
960:PDCD4
945:exons
926:PDPK1
878:eIF4B
870:eIF4A
866:eIF4G
862:eIF4E
815:DDIT4
811:HIF1A
791:STK11
745:like
728:GSK3B
610:upon
539:Sec13
535:Seh1L
531:WDR59
527:WDR24
519:NPRL3
515:NPRL2
443:is a
371:MLST8
302:q25.3
293:Locus
245:30287
233:57521
213:RPTOR
198:RPTOR
144:Locus
8970:list
8963:EC7
8957:list
8950:EC6
8944:list
8937:EC5
8931:list
8924:EC4
8918:list
8911:EC3
8905:list
8898:EC2
8892:list
8885:EC1
8461:TPK1
8437:CDC7
8395:MLKs
8388:KSR2
8383:KSR1
8378:BRAF
8373:ARAF
8368:RAFs
8103:CDK9
8098:CDK8
8093:CDK7
8088:CDK6
8078:CDK5
8073:CDK4
8068:CDK3
8058:CDK2
8053:CDK1
8034:PLK4
8029:PLK3
8024:PLK2
8019:PLK1
7974:PLK4
7969:PLK3
7964:PLK2
7959:PLK1
7906:PHKB
7862:MYLK
7833:TRIO
7803:SPEG
7798:SNRK
7758:PKD1
7753:PIM2
7748:PIM1
7733:PASK
7703:MELK
7633:CASK
7628:MLCK
7549:GRK6
7544:GRK5
7539:GRK4
7477:PKN3
7472:PKN2
7374:PRKY
7320:TBK1
7315:IKK2
7310:CHUK
7214:STK4
7180:IDH2
7065:PDK4
7060:PDK3
7055:PDK2
7050:PDK1
7029:WEE1
7024:Wee1
6992:mTOR
6980:AKT3
6975:AKT2
6970:AKT1
6960:SGK3
6955:SGK2
6805:PMID
6748:PMID
6707:PMID
6650:PMID
6593:PMID
6534:ISBN
6499:PMID
6434:PMID
6391:PMID
6356:PMID
6313:PMID
6278:PMID
6229:PMID
6169:PMID
6130:PMID
6095:PMID
6060:PMID
6011:PMID
5952:PMID
5911:PMID
5862:PMID
5813:PMID
5778:PMID
5724:PMID
5675:PMID
5618:PMID
5577:PMID
5538:PMID
5497:PMID
5470:PMID
5419:PMID
5363:PMID
5311:PMID
5254:PMID
5203:PMID
5154:PMID
5102:PMID
5053:PMID
5001:PMID
4952:PMID
4903:PMID
4854:PMID
4795:PMID
4760:PMID
4711:PMID
4654:PMID
4619:PMID
4578:PMID
4522:PMID
4481:PMID
4432:PMID
4397:PMID
4348:PMID
4299:PMID
4250:PMID
4212:PMID
4163:PMID
4112:PMID
4071:PMID
4014:PMID
3957:PMID
3914:PMID
3873:PMID
3824:PMID
3806:Cell
3775:PMID
3726:PMID
3675:PMID
3623:PMID
3574:PMID
3556:Cell
3533:PMID
3498:PMID
3449:PMID
3414:PMID
3379:PMID
3338:PMID
3289:PMID
3240:PMID
3181:PMID
3130:PMID
3081:PMID
3024:PMID
2989:PMID
2965:2012
2938:PMID
2884:PMID
2835:PMID
2794:PMID
2735:PMID
2678:PMID
2660:Cell
2637:PMID
2588:PMID
2539:PMID
2488:PMID
2428:PMID
2388:PMID
2331:PMID
2274:PMID
2239:PMID
2182:PMID
2133:PMID
2076:PMID
2027:PMID
1978:PMID
1937:PMID
1888:PMID
1839:PMID
1780:PMID
1729:PMID
1711:Cell
1685:PMID
1636:PMID
1618:Cell
1588:PMID
1536:and
1526:Rheb
1480:and
1383:and
1333:EGCG
1311:and
1284:The
1147:NRF2
1042:Atg1
1038:ULK1
1017:via
968:BTRC
911:eIF3
886:mRNA
776:AMPK
751:IKK2
721:The
706:MAPK
659:GRB2
643:IGF1
601:S6K1
599:and
523:Mios
517:and
496:and
453:Rheb
441:TSC2
402:and
377:and
363:mTOR
252:OMIM
240:HGNC
91:OMIM
84:3942
79:HGNC
72:2475
52:MTOR
25:mTOR
8466:TTK
8430:ZAK
7007:HRI
7002:PKR
6950:SGK
6940:CIT
6795:PMC
6787:doi
6775:493
6738:doi
6697:PMC
6689:doi
6640:PMC
6632:doi
6620:552
6583:PMC
6575:doi
6526:doi
6489:PMC
6481:doi
6469:335
6426:doi
6383:doi
6348:doi
6305:doi
6301:177
6268:PMC
6260:doi
6219:PMC
6211:doi
6161:doi
6122:doi
6087:doi
6050:PMC
6042:doi
6001:PMC
5991:doi
5942:doi
5901:PMC
5893:doi
5852:PMC
5844:doi
5805:doi
5768:PMC
5760:doi
5714:PMC
5706:doi
5665:PMC
5657:doi
5645:335
5608:doi
5569:doi
5528:doi
5460:PMC
5450:doi
5446:285
5409:PMC
5399:doi
5353:PMC
5345:doi
5341:235
5301:PMC
5293:doi
5281:460
5244:PMC
5234:doi
5193:PMC
5185:doi
5181:138
5144:PMC
5136:doi
5092:PMC
5084:doi
5043:PMC
5035:doi
4991:PMC
4983:doi
4942:PMC
4934:doi
4893:PMC
4885:doi
4844:PMC
4834:doi
4822:108
4787:doi
4750:PMC
4742:doi
4701:PMC
4693:doi
4689:417
4646:doi
4609:doi
4568:PMC
4560:doi
4512:doi
4471:doi
4467:275
4424:doi
4387:PMC
4379:doi
4338:PMC
4330:doi
4289:PMC
4281:doi
4242:doi
4238:368
4202:doi
4155:doi
4143:310
4102:doi
4061:PMC
4053:doi
4041:460
4004:PMC
3996:doi
3949:doi
3937:292
3904:doi
3900:280
3863:doi
3859:280
3814:doi
3810:133
3765:doi
3718:doi
3706:279
3665:doi
3653:410
3613:doi
3609:277
3564:doi
3560:123
3525:doi
3488:PMC
3480:doi
3472:RNA
3441:doi
3406:doi
3369:doi
3328:PMC
3320:doi
3316:122
3279:PMC
3271:doi
3230:PMC
3220:doi
3208:107
3171:PMC
3161:doi
3120:PMC
3112:doi
3071:PMC
3063:doi
3016:doi
2979:PMC
2969:doi
2928:PMC
2918:doi
2874:hdl
2866:doi
2862:443
2825:doi
2821:140
2784:PMC
2774:doi
2770:287
2725:doi
2668:doi
2664:121
2627:PMC
2619:doi
2578:PMC
2570:doi
2529:PMC
2519:doi
2515:282
2478:PMC
2470:doi
2420:doi
2378:PMC
2370:doi
2358:340
2321:PMC
2313:doi
2266:doi
2229:PMC
2221:doi
2209:320
2172:PMC
2164:doi
2123:PMC
2115:hdl
2107:doi
2066:PMC
2058:doi
2017:PMC
2009:doi
1968:doi
1927:PMC
1919:doi
1878:PMC
1870:doi
1829:PMC
1819:doi
1772:doi
1760:294
1719:doi
1715:124
1675:doi
1626:doi
1622:110
1578:doi
1499:of
1460:RTK
1315:of
1094:TOR
941:EJC
904:S6K
890:40S
884:of
772:AMP
768:ATP
702:JNK
679:RSK
675:Erk
671:Mek
667:Raf
585:Akt
457:GTP
449:GAP
373:),
350:or
153:p36
9010::
7116:γ
7101:β
7086:α
6874:EC
6868::
6803:.
6793:.
6785:.
6773:.
6769:.
6746:.
6734:26
6732:.
6728:.
6705:.
6695:.
6687:.
6675:.
6671:.
6648:.
6638:.
6630:.
6618:.
6614:.
6591:.
6581:.
6573:.
6563:10
6561:.
6557:.
6532:.
6497:.
6487:.
6479:.
6467:.
6463:.
6440:.
6432:.
6420:.
6397:.
6389:.
6379:21
6377:.
6354:.
6344:18
6342:.
6319:.
6311:.
6299:.
6276:.
6266:.
6256:24
6254:.
6250:.
6227:.
6217:.
6207:16
6205:.
6201:.
6189:^
6175:.
6167:.
6157:59
6155:.
6151:.
6128:.
6118:18
6116:.
6093:.
6083:25
6081:.
6058:.
6048:.
6038:25
6036:.
6032:.
6009:.
5999:.
5985:.
5981:.
5958:.
5950:.
5938:94
5936:.
5932:.
5909:.
5899:.
5887:.
5883:.
5860:.
5850:.
5840:15
5838:.
5834:.
5811:.
5801:39
5799:.
5776:.
5766:.
5756:10
5754:.
5750:.
5736:^
5722:.
5712:.
5702:14
5700:.
5696:.
5673:.
5663:.
5655:.
5643:.
5639:.
5616:.
5604:22
5602:.
5598:.
5575:.
5565:12
5563:.
5536:.
5524:28
5522:.
5518:.
5493:32
5491:.
5468:.
5458:.
5444:.
5440:.
5417:.
5407:.
5393:.
5389:.
5375:^
5361:.
5351:.
5339:.
5335:.
5323:^
5309:.
5299:.
5291:.
5279:.
5275:.
5252:.
5242:.
5228:.
5224:.
5201:.
5191:.
5179:.
5175:.
5152:.
5142:.
5130:.
5126:.
5114:^
5100:.
5090:.
5080:24
5078:.
5074:.
5051:.
5041:.
5031:24
5029:.
5025:.
5013:^
4999:.
4989:.
4977:.
4973:.
4950:.
4940:.
4930:55
4928:.
4924:.
4901:.
4891:.
4881:12
4879:.
4875:.
4852:.
4842:.
4832:.
4820:.
4816:.
4793:.
4781:.
4758:.
4748:.
4736:.
4732:.
4709:.
4699:.
4687:.
4683:.
4660:.
4652:.
4642:55
4640:.
4617:.
4605:75
4603:.
4599:.
4576:.
4566:.
4556:70
4554:.
4550:.
4534:^
4520:.
4508:12
4506:.
4502:.
4479:.
4465:.
4461:.
4438:.
4430:.
4420:35
4418:.
4395:.
4385:.
4375:44
4373:.
4369:.
4346:.
4336:.
4326:32
4324:.
4320:.
4297:.
4287:.
4275:.
4271:.
4248:.
4236:.
4224:^
4210:.
4196:.
4192:.
4169:.
4161:.
4153:.
4141:.
4118:.
4110:.
4098:36
4096:.
4092:.
4069:.
4059:.
4051:.
4039:.
4035:.
4012:.
4002:.
3992:15
3990:.
3986:.
3963:.
3955:.
3947:.
3935:.
3912:.
3898:.
3894:.
3871:.
3857:.
3853:.
3830:.
3822:.
3808:.
3804:.
3781:.
3773:.
3763:.
3751:.
3747:.
3724:.
3716:.
3704:.
3681:.
3673:.
3663:.
3651:.
3647:.
3635:^
3621:.
3607:.
3603:.
3580:.
3572:.
3558:.
3554:.
3531:.
3519:.
3496:.
3486:.
3476:12
3474:.
3470:.
3447:.
3437:31
3435:.
3412:.
3402:24
3400:.
3377:.
3365:25
3363:.
3359:.
3336:.
3326:.
3314:.
3310:.
3287:.
3277:.
3267:18
3265:.
3261:.
3238:.
3228:.
3218:.
3206:.
3202:.
3179:.
3169:.
3157:14
3155:.
3151:.
3128:.
3118:.
3108:30
3106:.
3102:.
3079:.
3069:.
3059:13
3057:.
3053:.
3030:.
3022:.
3010:.
2987:.
2977:.
2963:.
2959:.
2936:.
2926:.
2914:11
2912:.
2908:.
2896:^
2882:.
2872:.
2860:.
2856:.
2833:.
2819:.
2815:.
2792:.
2782:.
2768:.
2764:.
2741:.
2733:.
2723:.
2713:18
2711:.
2707:.
2684:.
2676:.
2662:.
2658:.
2635:.
2625:.
2613:.
2609:.
2586:.
2576:.
2564:.
2560:.
2537:.
2527:.
2513:.
2509:.
2486:.
2476:.
2466:36
2464:.
2460:.
2448:^
2434:.
2426:.
2416:10
2414:.
2400:^
2386:.
2376:.
2368:.
2356:.
2352:.
2329:.
2319:.
2309:43
2307:.
2303:.
2280:.
2272:.
2260:.
2237:.
2227:.
2219:.
2207:.
2203:.
2180:.
2170:.
2160:18
2158:.
2154:.
2131:.
2121:.
2113:.
2103:18
2101:.
2097:.
2074:.
2064:.
2054:14
2052:.
2048:.
2025:.
2015:.
2005:13
2003:.
1999:.
1976:.
1964:32
1962:.
1958:.
1935:.
1925:.
1915:30
1913:.
1909:.
1886:.
1876:.
1866:82
1864:.
1860:.
1837:.
1827:.
1815:13
1813:.
1809:.
1786:.
1778:.
1770:.
1758:.
1735:.
1727:.
1713:.
1709:.
1697:^
1683:.
1671:11
1669:.
1665:.
1642:.
1634:.
1620:.
1616:.
1600:^
1586:.
1574:18
1572:.
1568:.
1554:^
1503:.
1484:.
1476:,
1445:.
1403:.
1351:.
1343:,
1339:,
1335:,
1281:.
1269:,
1225:.
1115:.
1076:,
998:.
692:.
630:.
549:.
537:,
533:,
529:,
525:,
513:,
8986::
8972:)
8968:(
8959:)
8955:(
8946:)
8942:(
8933:)
8929:(
8920:)
8916:(
8907:)
8903:(
8894:)
8890:(
8714:e
8707:t
8700:v
8523:-
8506:-
8489:-
7292:-
6872:(
6858:e
6851:t
6844:v
6811:.
6789::
6781::
6754:.
6740::
6713:.
6691::
6683::
6677:9
6656:.
6634::
6626::
6599:.
6577::
6569::
6542:.
6528::
6505:.
6483::
6475::
6448:.
6428::
6422:8
6405:.
6385::
6362:.
6350::
6327:.
6307::
6284:.
6262::
6235:.
6213::
6183:.
6163::
6136:.
6124::
6101:.
6089::
6066:.
6044::
6017:.
5993::
5987:8
5966:.
5944::
5917:.
5895::
5889:5
5868:.
5846::
5819:.
5807::
5784:.
5762::
5730:.
5708::
5681:.
5659::
5651::
5624:.
5610::
5583:.
5571::
5544:.
5530::
5503:.
5476:.
5452::
5425:.
5401::
5395:7
5369:.
5347::
5317:.
5295::
5287::
5260:.
5236::
5230:3
5209:.
5187::
5160:.
5138::
5132:2
5108:.
5086::
5059:.
5037::
5007:.
4985::
4979:6
4958:.
4936::
4909:.
4887::
4860:.
4836::
4828::
4801:.
4789::
4783:7
4766:.
4744::
4738:5
4717:.
4695::
4668:.
4648::
4625:.
4611::
4584:.
4562::
4528:.
4514::
4487:.
4473::
4446:.
4426::
4403:.
4381::
4354:.
4332::
4305:.
4283::
4277:8
4256:.
4244::
4218:.
4204::
4198:9
4177:.
4157::
4149::
4126:.
4104::
4077:.
4055::
4047::
4020:.
3998::
3971:.
3951::
3943::
3920:.
3906::
3879:.
3865::
3838:.
3816::
3789:.
3767::
3759::
3753:8
3732:.
3720::
3712::
3689:.
3667::
3659::
3629:.
3615::
3588:.
3566::
3539:.
3527::
3521:4
3504:.
3482::
3455:.
3443::
3420:.
3408::
3385:.
3371::
3344:.
3322::
3295:.
3273::
3246:.
3222::
3214::
3187:.
3163::
3136:.
3114::
3087:.
3065::
3038:.
3018::
3012:8
2995:.
2971::
2944:.
2920::
2890:.
2876::
2868::
2841:.
2827::
2800:.
2776::
2749:.
2727::
2719::
2692:.
2670::
2643:.
2621::
2615:3
2594:.
2572::
2566:7
2545:.
2521::
2494:.
2472::
2442:.
2422::
2394:.
2372::
2364::
2337:.
2315::
2288:.
2268::
2262:5
2245:.
2223::
2215::
2188:.
2166::
2139:.
2117::
2109::
2082:.
2060::
2033:.
2011::
1984:.
1970::
1943:.
1921::
1894:.
1872::
1845:.
1821::
1794:.
1774::
1766::
1743:.
1721::
1691:.
1677::
1650:.
1628::
1594:.
1580::
1245:L
1145:(
1092:m
1080:/
726:(
430:.
397:L
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.